Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 20192020

 

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934

For the transition period from ________________ to ________________

 

Commission File Number 001-35073

 


 

GEVO, INC.

(Exact name of registrant as specified in its charter)

 


 

Delaware

 

87-0747704

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

345 Inverness Drive South, Building C, Suite 310

Englewood, CO

345 Inverness Drive South, Building C, Suite 310

Englewood, CO

80112

(Address of principal executive offices)

(Zip Code)

(303) 858-8358

(Address, including zip code, andRegistrant's telephone number, including

including area code, of registrant’s principal executive offices)code)

 


Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

Common Stock, par value $0.01 per share

GEVO

Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer

 

 

Accelerated filer

 

       

Non-accelerated filer

 

 

Smaller reporting company

 

       

 

 

 

 

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class

Trading Symbol

Name of Each Exchange on Which Registered

Common Stock, par value $0.01 per share

GEVO

Nasdaq Capital Market

As of April 30, 2019, 11,885,5242020, 14,883,077 shares of the registrant’s common stock were outstanding.

 



 

 

 

 

GEVO, INC.

 

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 20192020

TABLE OF CONTENTS

 

 

 

Page

PART I.  FINANCIAL INFORMATION
   

Item 1.

Financial Statements

3

 

Consolidated Balance Sheets as of March 31, 20192020 (unaudited) and December 31, 20182019

3

 

Consolidated Statements of Operations for the three months ended March 31, 2020 and 2019 and 2018 (unaudited)

4
Consolidated Statements of Stockholders' Equity for the three months ended March 31, 2020 and 2019 (unaudited)5

 

Consolidated Statements of Cash Flows for the three months ended March 31, 2020 and 2019 and 2018 (unaudited)

56

 

Notes to Consolidated Financial Statements (unaudited)

78

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

2430

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

3038

Item 4.

Controls and Procedures

3038

 

 

 

PART II.  OTHER INFORMATION

  

 

 

Item 1.

Legal Proceedings

3139

Item 1A.

Risk Factors

3139

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

3240

Item 3.

Defaults Upon Senior Securities

3240

Item 4.

Mine Safety Disclosures

3240

Item 5.

Other Information

3240

Item 6.

Exhibits

3241

 

 

 

 

Signatures

3544

 

2

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

GEVO, INC.

Consolidated Balance Sheets

(in thousands, except share and per share amounts)

 

 

 

March 31,

2019

(unaudited)

  

December 31,

2018

  

 

March 31,

2020

(unaudited)

  

December 31,

2019

 

Assets

                

Current assets:

                

Cash and cash equivalents

 $35,466  $33,734  $9,289  $16,302 

Accounts receivable

  1,125   526   152   1,135 

Inventories

  3,187   3,166   2,680   3,201 

Prepaid expenses and other current assets

  1,902   1,284   3,838   3,590 

Total current assets

  41,680   38,710   15,959   24,228 
                

Property, plant and equipment, net

  68,045   67,036   65,855   66,696 
Investment in Juhl 1,500  1,500 

Deposits and other assets

  1,738   1,289   848   935 
      

Total assets

 $111,463  $107,035  $84,162  $93,359 
                

Liabilities

                

Current liabilities:

                

Accounts payable and accrued liabilities

 $5,147  $4,874  $4,477  $5,678 
2020/21 Notes (current), net 14,050   
2020 Notes (current), net 12,964      13,900 

2020 Notes embedded derivative liability

  148   394 

Derivative warrant liability

  21   22 

2020/21 Notes embedded derivative liability

  100    

Loans payable - other (current)

  375   516 

Total current liabilities

  18,280   5,290   19,002   20,094 
                

2020 Notes (long-term), net

     12,554 

Loans payable - other (long-term)

  232   233 

Other long-term liabilities

  654   404   435   528 

Total liabilities

  18,934   18,248   19,669   20,855 
                

Commitments and Contingencies (see Note 11)

                
                

Stockholders' Equity

                

Common stock, $0.01 par value per share; 250,000,000 authorized; 11,885,524 and 8,640,583 shares issued and outstanding at March 31, 2019 and December 31, 2018, respectively.

  119   86 

Common stock, $0.01 par value per share; 250,000,000 authorized; 14,614,890 and 14,083,232 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively.

  145   141 

Additional paid-in capital

  527,872   518,027   531,587   530,349 

Accumulated deficit

  (435,462)  (429,326)  (467,239)  (457,986)

Total stockholders' equity

  92,529   88,787   64,493   72,504 
      

Total liabilities and stockholders' equity

 $111,463  $107,035  $84,162  $93,359 

 

See the accompanying Notes to the unaudited Consolidated Financial Statements.

 

3

 

 

GEVO, INC.

Consolidated Statements of Operations

(in thousands, except share and per share amounts)

(unaudited)

 

 

Three Months Ended March 31,

  

Three Months Ended March 31,

 
 2019  

2018

  2020  

2019

 

Revenue

        

Revenue and cost of goods sold

        

Ethanol sales and related products, net

 $5,664  $8,218  $3,700  $5,664 

Hydrocarbon revenue

  739      125   739 

Grant and other revenue

     25 

Total revenues

  6,403   8,243   3,825   6,403 
                

Cost of goods sold

  8,961   10,583   8,139   8,961 
                

Gross loss

  (2,558)  (2,340

)

  (4,314)  (2,558

)

                

Operating expenses

                

Research and development expense

  978   789   580   978 

Selling, general and administrative expense

  2,092   1,870   2,783   2,092 
Restructuring expenses  299    

Total operating expenses

  3,070   2,659   3,662   3,070 
                

Loss from operations

  (5,628)  (4,999

)

  (7,976)  (5,628

)

                

Other (expense) income

        

Other income (expense)

        

Interest expense

  (755)  (825

)

  (545)  (755

)

(Loss) on exchange of debt

     (21

)

(Loss) on modification of 2020 Notes

  (669)  

 

Gain from change in fair value of derivative warrant liability

  1   477   7   1 

Gain from change in fair value of 2020 Notes embedded derivative

  246   2,858 

(Loss) gain from change in fair value of 2020/21 Notes and 2020 Notes embedded derivative liability

  (100)  246 

Other income

     8   30    

Total other expense, net

  (508)  2,497 

Total other income (expense), net

  (1,277)  (508)
                

Net loss

 $(6,136)  $(2,502

)

 $(9,253)  $(6,136

)

                

Net loss per share - basic and diluted

 $(0.60)  $(2.22

)

 $(0.64)  $(0.60

)

      

Weighted-average number of common shares outstanding - basic and diluted

  10,153,873   1,126,737   14,472,798   10,153,873 

 

See the accompanying Notes to the unaudited Consolidated Financial Statements.

 

4

 

 

GEVO, INC.

Consolidated Statements of Cash FlowsCONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(in thousands)In thousands, except share amounts)

(unaudited)

 

  

Three Months Ended March 31,

 
  2019  

2018

 

Operating Activities

        

Net loss

 $(6,136) $(2,502

)

Adjustments to reconcile net loss to net cash used in operating activities:

        

(Gain) from change in fair value of derivative warrant liability

  (1)  (477

)

(Gain) from change in fair value of 2020 Notes embedded derivative

  (246)  (2,858

)

Loss on exchange of debt

     21 

Stock-based compensation

  234   98 

Depreciation and amortization

  1,612   1,646 

Non-cash interest expense

  410   402 

Changes in operating assets and liabilities:

        

Accounts receivable

  (599)  (234

)

Inventories

  (21)  7 

Prepaid expenses and other current assets

  157   78 

Accounts payable, accrued expenses, and long-term liabilities

  (1,118)  (531

)

Net cash used in operating activities

  (5,708)  (4,350

)

         

Investing Activities

        

Acquisitions of property, plant and equipment

  (2,204)  (67

)

Net cash used in investing activities

  (2,204)  (67

)

         
         

Financing Activities

        

Proceeds from issuance of common stock and common stock warrants, net

  9,644   (107)

Net cash (used in)/provided by financing activities

  9,644   (107

)

         

Net increase (decrease) in cash and cash equivalents

  1,732   (4,524

)

         

Cash, cash equivalents, and restricted cash

        

Beginning of period

  33,734   11,553 

End of period

 $35,466  $7,029 
  

Common Stock

  

Paid-In

  

Accumulated

  

Stockholders’

 
  

Shares

  

Amount

  

Capital

  

Deficit

  

Equity

 
                     

Balance, December 31, 2019

  14,083,232  $141  $530,349  $(457,986

)

 $72,504 
                     

Issuance of common stock, net of issue costs 

  425,776   4   902      906 

Non-cash stock-based compensation

        336      336 
Issuance of common stock under stock plans, net of taxes  105,882             

Net loss

           (9,253

)

  (9,253)
                     
Balance, March 31, 2020  14,614,890  $145  $531,587  $(467,239) $64,493 
                     

Balance, December 31, 2018

  8,640,583  $86  $518,027  $(429,326

)

 $88,787 
                     

Issuance of common stock, net of issue costs

  3,244,941   33   9,611      9,644 

Non-cash stock-based compensation

        234      234 

Net loss

           (6,136)  (6,136)
                     

Balance, March 31, 2019

  11,885,524  $119  $527,872  $(435,462) $92,529 

 

See the accompanying Notes to the unaudited Consolidated Financial Statements.

 

5

GEVO, INC.

Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

  

Three Months Ended March 31,

 
  2020  

2019

 

Operating Activities

        

Net loss

 $(9,253) $(6,136

)

Adjustments to reconcile net loss to net cash used in operating activities:

        

(Gain) from change in fair value of derivative warrant liability

  (7)  (1

)

(Gain) from change in fair value of 2020/21 Notes and 2020 Notes embedded derivative liability

  100   (246

)

Stock-based compensation

  172   263 

Depreciation and amortization

  1,649   1,612 
Non-cash lease expense  15   12 

Non-cash interest expense

  150   410 

Changes in operating assets and liabilities:

        

Accounts receivable

  983   (599

)

Inventories

  520   (21)

Prepaid expenses and other current assets, deposits and other assets

  (167)  157 

Accounts payable, accrued expenses, and long-term liabilities

  (1,150)  (1,159

)

Net cash used in operating activities

  (6,988)  (5,708

)

         

Investing Activities

        

Acquisitions of property, plant and equipment

  (777)  (2,204

)

Net cash used in investing activities

  (777)  (2,204

)

         
         

Financing Activities

        
Debt and equity offering costs  (52)  (234)

Proceeds from issuance of common stock, net

  958   9,878 
Payment of loans payable - other  (154)   

Net cash provided by financing activities

  752   9,644

 

         

Net (decrease) increase in cash and cash equivalents

  (7,013)  1,732

 

         

Cash and cash equivalents

        

Beginning of period

  16,302   33,734 
         

End of period

 $9,289  $35,466 

See the accompanying Notes to the unaudited Consolidated Financial Statements.

6

 

GEVO, INC. 

Consolidated Statements of Cash Flows - Continued

(in thousands)

(unaudited)

 

Supplemental disclosures of cash and non-cash investing and financing transactions

 

Three Months Ended March 31,

 
  2019  

2018

 

Cash paid for interest, net of interest capitalized

 $  $434 

Non-cash purchase of property, plant and equipment

 $1,316  $1 

Exchange of convertible debt into common stock

 $  $515 
Fair value of right-to-use asset and related lease liability upon adoption of Topic 842 - Leases $1,244    

Supplemental disclosures of cash and non-cash investing and financing transactions

 

Three Months Ended March 31,

 
  2020  

2019

 
         

Cash paid for interest

 $

395

  $345 
Non-cash purchase of property, plant and equipment $380  $1,316 
Original issue discount paid with 2020/21 Notes $282  $ 
Right-of-use asset purchased with financing lease $13  $ 
Fair value of right-to-use asset and related lease liability upon adoption of ASC 842 - Leases $  $1,244 

 

See the accompanying Notes to the unaudited Consolidated Financial Statements.

 

6
7

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

 

1. Nature of Business, Financial Condition and Basis of Presentation and Reverse Stock Split

 

Nature of Business.Business.  Gevo, Inc. (“Gevo” or the “Company,” which, unless otherwise indicated, refers to Gevo, Inc. and its subsidiaries) is a growth-oriented renewable chemicals andfuels company that is commercializing the next generation “low-carbon” fuel company focused on the development and commercialization of renewable low-carbon liquid transportation fuels with the potential to achieve “net zero” greenhouse gas (“GHG”) footprint and address global needs of reducing GHG emissions with sustainable alternatives to petroleum-based products. Low-carbonpetroleum fuels. As next generation renewable fuels, reduceGevo’s hydrocarbon transportation fuels have the advantage of being “drop-in” substitutes for conventional fuels that are derived from crude oil, working seamlessly and without modification in existing fossil-fuel based engines, supply chains and storage infrastructure. In addition to the potential of net zero carbon intensity, oremissions across the levelwhole of greenhouse gas emissions (“GHG”), compared to standard fossil-basedthe fuel life-cycle, Gevo’s renewable fuels across their lifecycle. The most commoneliminate other pollutants associated with the burning of traditional fossil fuels such as particulates and sulfur, while delivering superior performance. Gevo believes that the world is substantially under-supplied with low-carbon, drop-in renewable fuels are renewable fuels.that can be immediately used in existing transportation engines and infrastructure, and Gevo is focused onuniquely positioned to grow in serving that demand.

Gevo’s production processes and fuel products have been proven to work. Gevo uses low-carbon, renewable resource-based carbohydrates as raw materials. In the developmentnear-term, Gevo’s feedstocks will primarily consist of non-food corn. As Gevo’s technology is applied globally, feedstocks can consist of sugar cane, molasses or other cellulosic sugars derived from wood, agricultural residues and productionwaste. Gevo’s patented fermentation yeast biocatalyst produces isobutanol, a four-carbon alcohol, via the fermentation of mainstream fuels likerenewable plant biomass carbohydrates. The resulting renewable isobutanol has a variety of direct applications but, more importantly to Gevo’s fundamental strategy, serves as a building block to make renewable gasoline and jet fuel using simple and common chemical conversion processes. Gevo also plans to reduce or eliminate fossil-based process energy inputs by replacing them with renewable feedstocks that have the potential to lower GHG at a meaningful scaleenergy such as wind-powered electricity and enhance agricultural production, including food and other related products. In addition to serving the low-carbon fuel markets, through Gevo's technology, Gevo can also serve markets for the production of chemical intermediate products for solvents, plastics and building block chemicals.renewable natural gas (“RNG”).

 

In addition to its ethanol production capabilities, the Company developed proprietary technology that uses a combination of synthetic biology, metabolic engineering, chemistry and chemical engineering to make isobutanol and hydrocarbon products from isobutanol that can displace petrochemical incumbent products. The Company has been able to genetically engineer yeast, whereby the yeast produces isobutanol from carbohydrates. The Company’s technology converts its renewable isobutanol to alcohol-to-jet (“ATJ”), isooctane, isooctene, and para-xylene (building block for polyester) at its hydrocarbons demonstration plant located at South Hampton Resources, Inc’s facility in Silsbee, Texas (the “South Hampton Facility”). In addition the Company’s production facility located in Luverne, Minnesota (the “Luverne Facility”) has production capacity of about 20 million gallons per year of ethanol, 45-50 kilotons of animal feed, and 3 million pounds of corn oil.

As of March 31, 2019, the Company continues to engage in research and development, business development, business and financial planning, optimizing operations for low-carbon ethanol, isobutanol, and related hydrocarbons production and raising capital to fund future expansion of its Luverne Facility. Ultimately, the Company believes that the attainment of profitable operations is dependent upon future events, including (i) completing certain capital improvements at the Company’s production facility located in Luverne, FacilityMinnesota (the "Luverne Facility") to produce low-carbon ethanol side-by-side with low-carbonincrease the production capacity of renewable gasoline and jet fuel and other related products that can be made from isobutanol; (ii) completing the Company’sCompany's development activities resulting in commercial production and sales of low-carbon ethanol, isobutanol, or isobutanol derived products and/or technology;renewable hydrocarbon products; (iii) obtaining adequate financing to complete the Company’sCompany's development activities, including the build out of low-carbon ethanol capacity and further isobutanol andrenewable hydrocarbon capacity; (iv) gaining market acceptance and demand for the Company’sCompany's products and services; (v) attracting and retaining qualified personnel; and (vi) the achievement ofachieving a level of revenues adequate to support the Company’sCompany's cost structure.

 

COVID-19.  The novel coronavirus ("COVID-19") pandemic has had an adverse impact on global commercial activity, including the global transportation industry and its supply chain, and has contributed to significant volatility in the financial markets including, among other effects, a decline in the equity markets and reduced liquidity generally for many companies, including the Company. In light of the potential future disruption to the Company's business operations and those of its customers, suppliers and other third parties with whom the Company interacts, the Company considered the impact of the COVID-19 pandemic on its business. This analysis considered the Company's resilience and continuity plans, financial modeling and stress testing of liquidity and financial resources.

The analysis concluded that the COVID-19 pandemic did not have a material adverse impact to the Company's financial results for the first quarter of 2020. Although the COVID-19 pandemic did not have a material adverse impact to the Company’s financial results for the first quarter of 2020, the Company expects that the impact of the COVID-19 pandemic on general economic activity could negatively impact its revenue and operating results for the remainder of 2020. For example, in March 2020, following a temporary suspension of ethanol production at the Luverne Facility, the Company ultimately suspended production for the foreseeable future due to the impact of COVID-19 on the economy and its industry as a whole. There is also a risk that COVID-19 could have a material adverse impact on customer demand and cash flow for the remainder of 2020 and beyond. The Company will continue to monitor the situation and assess possible implications to its business and its stakeholders and will take appropriate actions to help mitigate adverse consequences. The extent to which COVID-19 impacts its business and financial position will depend on future developments, which are difficult to predict, including the severity, duration and scope of the COVID-19 outbreak as well as the types of measures imposed by governmental authorities to contain the virus or address its impact and the duration of those actions and measures.

The Company has considered multiple scenarios, with both positive and negative inputs, as part of the significant estimates and assumptions that are inherent in its financial statements and are based on trends in customer behavior and the economic environment throughout the quarter and beyond as the COVID-19 pandemic has impacted the industries in which the Company operates. These estimates and assumptions include the collectability of billed and unbilled receivables, the estimation of revenue and tangible and intangible assets. With regard to collectability, the Company believes it may face atypical delays in client payments going forward. In addition, management believes that the demand for certain discretionary lines of business may decrease, and that such decrease will impact our financial results in succeeding periods. Non-discretionary lines of business may also be adversely affected, for example because reduced economic activity or disruption in hydrocarbon markets reduces demand for or the extent of renewable alcohol-to-jet fuel (“ATJ”), isooctane and isooctene. The Company believes that these trends and uncertainties are comparable to those faced by other registrants as a result of the pandemic.

8

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

Following a temporary suspension of ethanol production at the Luverne Facility, the Company ultimately suspended production for the foreseeable future due to the impact of COVID-19, including its effect on the economy and the Company’s industry as a whole. With these steps, the Company expects to save several million dollars of cash burn during 2020.

In response to the impact of the COVID-19 pandemic, the Company reduced its workforce in March 2020, impacting 26 people at the Luverne Facility and four people at the Company's corporate headquarters. (See "Restructuring Expenses" below.) The Company also reduced, and each of Patrick R. Gruber, its Chief Executive Officer, Christopher M. Ryan, its President, Chief Operating Officer and Chief Technology Officer, L. Lynn Smull, its Chief Financial Officer, Timothy J. Cesarek, its Chief Commercial Officer, Geoffrey T. Williams, Jr., its General Counsel and Secretary, and Carolyn M. Romero, its Vice President - Controller and Principal Accounting Officer (collectively, the “Officers”) accepted 20% reductions to their base salaries. These reductions became effective as of April 1, 2020 for a period of 90 days thereafter. In connection with the 20% salary reduction, the Officers were granted Company stock in the form of restricted stock awards in an amount equal to the 20% reduction. Certain remaining employees that earn above a certain dollar threshold also agreed to take a 20% salary reduction over the next three months, with the 20% portion to be paid in the form of restricted stock awards.

In addition, in connection with the impact that the COVID-19 pandemic has had on the economy and on the resulting disruption to the airline industry specifically, the Company and Delta Air Lines, Inc. (“Delta”) amended portions of the Company's previously disclosed Fuel Sales Agreement (the “Delta Agreement”) on April 22, 2020 (the “Delta Amendment”).  The Delta Amendment provides that Delta may terminate the Delta Agreement if the Company does not notify Delta by June 30, 2024 that the facility for the production, refining and delivery of ATJ with a nameplate capacity of up to 12 million gallons per year (the “Facility”) has achieved commercial operation and the ability to produce and deliver the ATJ purchased pursuant to the Delta Agreement (the date upon which such operation occurs is referred to as the “Commencement Date”).

The Delta Amendment also revises the credit support terms in the Delta Agreement to state that the Company and Delta will work to mutually agree upon credit support terms for the take or pay that are acceptable to the Company’s lender to enable the Company to obtain third party financing prior to the earlier of the time that the Company obtains financing for construction of the Facility or otherwise issues a notice to commence construction of the Facility. If the Company and Delta are unable to agree on reasonable credit support terms, the Company may terminate the Delta Agreement. The balance of Delta’s credit support obligations were deleted.

In addition, the Delta Amendment revises the ATJ pricing in the Delta Agreement to the extent that if Brent Crude is below a certain cutoff price as of the date that is 60 days prior to the Commencement Date (the “Commencement Notice Date”), then the pricing adjusts based upon a formula related to the Brent crude prices as of the Commencement Notice Date. The Delta Amendment also provides that, if as of the Commencement Notice Date, the Brent Crude price is below the price adjustment range, Delta may eliminate the take-or-pay requirements of the Delta Agreement, which includes eliminating Delta’s obligation to take-or-pay the 10 million gallons per year of ATJ. Instead, the Delta Agreement would require the Company and Delta to agree at that time on the volumes and price of any ATJ to be sold under the Delta Agreement.

Restructuring Expenses. During the first quarter of 2020, the Company temporarily suspended and ultimately suspended for the foreseeable future its ethanol production at the Luverne Facility. In addition, due to the impact of the COVID-19 pandemic on the global economy and the Company’s industry, in March 2020, the Company reduced its workforce, impacting 26 people at the Luverne Facility and four people at the Company's corporate headquarters. Affected employees were offered a severance package which included a one-time payment, one month of health insurance and acceleration of vesting for any unvested restricted stock awards.

The Company incurred $0.1 million related to severance costs and $0.2 million related to lease agreements for which it will no longer receive value during the three months ended March 31, 2020, which are recorded as Restructuring expenses on the Consolidated Statements of Operations. Restructuring expense totaled $0.02 million and $0.3 million for Gevo and Gevo Development/Agri-Energy segments, respectively.

The Company intends to continue developing its hydrocarbon business, including the planned expansion of the Luverne Facility, and the Company expects to move forward in securing the project funding needed to expand the Luverne Facility. The expansion is designed to allow the Company to produce large quantities of low carbon isobutanol, sustainable aviation fuel and renewable isooctane. The Company also expects to continue engineering efforts for the expansion of isobutanol production and the construction of a commercial renewable hydrocarbon production facility, as well as additional decarbonization projects, at the Luverne Facility.

As of March 31, 2020, the Company had the following liabilities outstanding related to the restructuring expenses included in "Accounts payable and accrued liabilities" in the Consolidated Balance Sheets:

  

December 31, 2019

  

Additions

  

Payments

  

March 31, 2020

 
                 

Severance (including payroll taxes)

 $  $96  $  $96 

Lease agreements

     203      203 
                 

Total

 $  $299  $  $299 

Financial Condition. For the three months ended March 31, 20192020 and 2018,2019, the Company incurred a consolidated net loss of $6.1$9.3 million and $2.5$6.1 million, respectively, and had an accumulated deficit of $435.5$467.2 million atas of March 31, 2019.2020. The Company’s cash and cash equivalents atas of March 31, 20192020 totaled $35.5$9.3 million and are expected to be used for the following purposes: (i) operating activities of the Luverne Facility; (ii) operating activities at the Company’s corporate headquarters in Colorado, includingincluding research and development work; (iii) capital expenditures primarily(ii) development projects associated with the Luverne Facility, including capital expenditures to “de-carbonize” the Luverne Facility; (iv)RNG; (iii) exploration of strategic alternatives and new financings; (iv) debt service obligations; and (v) debt service and repayment obligations.maintaining the Luverne Facility;

 

7
9

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

The Company expects to incur future net losses as it continues to fund the development and commercialization of its product candidates. To date, the Company has financed its operations primarily with proceeds from multiple salesissuance of equity and debt securities, borrowings under debt facilities and product sales. The Company’s transition to profitability is dependent upon, among other things, the successful development and commercialization of its product candidates and the achievement of a level of revenues adequate to support the Company’s cost structure. The Company may never achieve profitability or positive cash flows, and unless and until it does, the Company will continue to need to raise additional cash.capital. Management intends to fund future operations through additional private and/or public offerings of debt or equity securities. In addition, the Company may seek additional capital through arrangements with strategic partners or from other sources, it may seek to restructure its debt and it will continue to address its cost structure. Notwithstanding, there can be no assurance that the Company will be able to raise additional funds or achieve or sustain profitability or positive cash flows from operations.

Existing working capital was not sufficient to meet the cash requirements to fund planned operations through the period that is one year after the date the Company’s financial statements for the three months ended March 31, 2020 were issued. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s inability to continue as a going concern may potentially affect the Company’s rights and obligations under its senior secured debt and issued and outstanding convertible notes. The accompanying financial statements have been prepared assuming that the Company will continue as a going concern and do not include adjustments that might result from the outcome of this uncertainty. This basis of accounting contemplates the recovery of the Company’s assets and the satisfaction of liabilities in the normal course of business.

At-the-Market Offering Program.In February 2018, the Company commenced an at-the-market offering program, which allows it to sell and issue shares of its common stock from time-to-time. TheIn August 2019, the at-the-market offering program was amended multiple times during 2018 to increase theprovide available capacity under the at-the-market offering program by an aggregate of approximately $84.9$10.7 million.

During the three months ended March 31, 2019,2020, the Company issued 3,244,941425,776 shares of common stock under the at-the-market offering program for grosstotal proceeds of $9.9 million. The Company paid$0.9 million, net of commissions to its sales agent of approximately $0.2 million and incurred other offering related expenses of $0.01 million during the three months ended March 31, 2019.

expenses. As of March 31, 2019,2020, the Company hadhas remaining capacity to issue and sell up to approximately $34.7$7.8 million of additional shares of common stock under the at-the-market offering program. However, pursuant to Instruction I.B.6 to Form S-3, because the Company’s market capitalization was below $75.0 million as of March 27, 2019, the date the Company filed its Annual Report on Form 10-K for the year ended December 31, 2018, the Company may only sell securities via Form S-3 if the aggregate market value of the securities sold by or on behalf of the Company during the twelve-month period immediately prior to and including the date of the sale is no more than one-third of all common voting and nonvoting equity held by non-affiliates of the Company.  Given the amount of common stock sold by the Company under the at-the-market offering program in 2018, the Company is currently unable to issue and sell additional shares of common stock under the at-the-market offering program.

 

Basis of Presentation. The unaudited consolidated financial statements of the Company (which include the accounts of its wholly-owned subsidiaries Gevo Development, LLC (“Gevo Development”) and Agri-Energy, LLC (“Agri-Energy”)) have been prepared, without audit, pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete financial statements. These statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary to present fairly the financial position, results of operations and cash flows of the Company at March 31, 20192020 and are not necessarily indicative of the results to be expected for the full year. These statements should be read in conjunction with the Company’s audited consolidated financial statements and notes thereto included under the heading “Financial Statements and Supplementary Data” in Part II, Item 8 of the Company’s Annual Report on Form 10-K for the year ended December 31, 2018.2019.

 

Reverse Stock Split.Income Taxes. On June 1, 2018,There is no provision for income taxes because the Company effected a reverse stock splithas incurred operating losses since inception.

Concentration of Business Risk.As of March 31, 2020, one customer, Air Total International SA, comprised approximately 52% of the Company's outstanding shares of its common stock by a ratio of one-for-twenty (the “Reverse Stock Split”), and its common stock began trading on the Nasdaq Capital Market on a Reverse Stock Split-basis on June 4, 2018. Unless otherwise indicated, all share amounts, per share data, share prices, exercise prices and conversion rates set forth in these notes and the accompanying unaudited consolidated financial statements have, where applicable, been adjusted retroactively to reflect this Reverse Stock Split.

Recent Accounting Pronouncements

Financial Instruments - Credit Losses (Topic 326). Measurement of Credit Losses on Financial Instruments.In June 2016, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update No. 2016-13, Financial Instruments - Credit Losses (Topic 326) Measurement of Credits Losses on Financial Instruments (“ASU 2016-13”), which replaces accounting for credit losses for most financial assets, including trade accounts receivable, respectively. As of December 31, 2019, three customers, Eco-Energy, LLC (Eco-Energy"), Purina Animal Nutrition, LLC ("Purina"), and certain other instruments that are not measured at fair value through income. ASU 2016-13 replaces the current “incurred loss” model, in which losses are recognized when a loss is incurred asHCS Group GmbH ("HCS") comprised 57%, 13% and 15% of the dateCompany's outstanding trade accounts receivable, respectively.

For the three months ended March 31, 2020 and 2019, Eco-Energy accounted for approximately 73% and 68% of the balance sheet, to an “expected credit loss” model, which includes a broader range of information to estimate expected credit losses over the lifetimeCompany's consolidated revenue, respectively. Purina represented approximately 22% and 18% of the financial asset. It is expected thatCompany's consolidated revenue for the adoption of this standard will primarily apply to the valuationthree months ended March 31, 2020 and 2019, respectively. All are customers of the Company’s trade accounts receivables. The Company sells primarily to a small quantity of large customers with significant balance sheets and those financial assets are often settled within one-to-two weeks after the completion of the corresponding sales transaction. While the Company is in the process of evaluating the impact, if any, that the adoption of this standard will have on the Company’s financial statements, it does not currently anticipate that this will have a material impact on the Company’s consolidated financial statements.Company's Gevo Development/Agri-Energy segment (see Note 14).

 

8
10

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

Adoption of New Accounting Pronouncements

Leases (Topic 842). In February 2016, the FASB issued ASU No. 2016-02, Topic 842 Leases (“ASU 2016-02”). ASU 2016-02 requires most contracts which convey over a period of time the right to use or control the use of an asset to be recognized on a company’s financial statements. The objective is to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. ASU 2016-02 was effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The standard required using the modified retrospective transition method and apply ASU 2016-02 either at the (i) latter of the earliest comparative period presented in the financial statements or commencement date of the lease, or (ii) beginning of the period of adoption. The Company adopted the standard effective January 1, 2019 with no retrospective adjustment to prior periods presented in the financial statements. There was no impact to the opening balance of retained earnings as of January 1, 2019 as a result of the adoption of this standard. 

As a result of adopting ASU 2016-02, the Company recognized $1.2 million in right-to-use assets and related lease liabilities at January 1, 2019. The Company elected to both (i) elect the short term lease scope exception for leases with original terms of twelve months or less and (ii) the package of practical expedients, which included the ability to classify leases as operating under the new standard, ASU 2016-02, for those leases existing prior to January 1, 2019 that were previously classified as operating under Topic 840 - Leases, the superseded accounting standard for the accounting for leases.

Derivatives and Hedging (Topic 815). Accounting for Certain Financial Instruments with Down Round Provisions. In July 2017, the FASB issued Accounting Standards Update No. 2017-11, Derivatives and Hedging (Topic 815) Accounting for Certain Financial Instruments with Down Round Provisions (“ASU 2017-11”), which was effective for fiscal years beginning after December 15, 2018, simplifies the accounting for certain equity-linked financial instruments and embedded features with down round features that reduce the exercise price when the pricing of a future round of financing is lower. Currently, the existence of such features require classification outside of equity and recognition of changes in the fair value of the instrument in earnings each reporting period. This standard eliminates the need to remeasure the instruments at fair value and allows classification within equity. The adoption of this standard has not materially impacted the Company’s accounting, as current liability classified financial instruments and embedded derivatives that require separation from the host instrument have features other than down-round provisions that require current accounting and classification.

9

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

 

2. Earnings Per Share

 

Basic earnings (loss) per share is computed by dividing the net loss for the period by the weighted-average number of common shares outstanding during the period. Diluted earnings (loss) per share (“EPS”) includes the dilutive effect of common stock equivalents and is computed using the weighted-average number of common stock and common stock equivalents outstanding during the reporting period. Diluted EPS for the three months ended March 31, 20192020 and 20182019 excluded common stock equivalents because the effect of their inclusion would be anti-dilutive, or would decrease the reported loss per share.

 

The following table sets forth securities outstanding that could potentially dilute the calculation of diluted earnings per share.share:

 

 

March 31,

  

March 31,

 
 2019  

2018

  2020 

2019

 

Warrants to purchase common stock - liability classified (see Note 6)

  55,963   359,619 
     

Warrants to purchase common stock - liability classified

 54,669 55,963 

Warrant to purchase common stock - equity classified

  6   70   6 

2020 Notes

  1,044,134   1,404,675 
Conversion of 2020/21 Notes 6,713,817  

Conversion of 2020 Notes

  1,044,134 

Outstanding options to purchase common stock

  2,311   2,322  1,561 2,311 
Stock appreciation rights 132,559    132,566 132,559 

Unvested restricted common stock

  284,300   111   284,300 
     

Total

  1,519,273   1,766,797  6,902,613 1,519,273 

 

 

3. Revenues from Contracts with Customers; Other Revenues

 

The Company’s current and historical revenues have consisted of the following: (a) ethanol sales and related products revenue, net; (b) hydrocarbon revenue; and (c) grant and other revenue, which primarily has historically consisted of revenues from governmental and cooperative research grants.

 

Ethanol sales and related products revenues. Ethanol sales and related products revenues are sold to customers on a “free-on-board,free-on-board, shipping point”point basis. Revenue is recognized when the customer has control of the product. Each transaction occurs independent of any other sale, and once sold, there are no future obligations on the part of the Company to provide post-sale support or promises to deliver future goods or services.

 

10
11

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

Hydrocarbon revenue. Hydrocarbon revenues include sales of ATJ, isooctene and isooctane and is sold mostly on a “free-on-board,free-on-board, shipping point”point basis. Revenue is recognized when the customer has control of the product. Each transaction occurs independent of any other sale, and once sold, there are no future obligations on the part of the Company to provide post-sale support or promises to deliver future goods or services.

Grant and other revenues. Grant and other revenues primarily have historically consisted of governmental and cooperative research grants, of which the Northwest Advanced Renewables Alliance grant, funded by the United States Department of Agriculture, comprised the majority of those revenues since 2014. After reviewing this arrangement, the Company has concluded that this grant consists of a non-reciprocal arrangement, and therefore, does not qualify as a contract pursuant to Topic 606 “Revenues from Contracts with Customers”. Other revenues have included historically occasional short-term (less than one-year) consulting services and leases of certain storage facilities located at the Company's Luverne Facility.

 

The following table sets forth the components of the Company’s revenues between those generated from contracts with customers and those generated from arrangements that do not constitute a contract with a customer (in thousands):

 

  

Three Months Ended March 31, 2019

 

Major Goods/Service Line

 

Revenues from

Contracts with

Customers

  

Other Revenues

  

Total

 

Ethanol sales and related products, net

 $5,664     $5,664 

Hydrocarbon revenue

  739      739 

Grant and other revenue

        - 
  $6,403  $  $6,403 

Timing of Revenue Recognition

            

Goods transferred at a point in time

 $6,403  $  $6,403 

Services transferred over time

        - 
  $6,403  $  $6,403 

Operating Segment

            

Gevo

 $739  $  $739 

Gevo Development / Agri-Energy

  5,664      5,664 
  $6,403  $  $6,403 

Geographic Region

            

United States

 $5,664  $  $5,664 

Other

  739      739 
  $6,403  $  $6,403 
  

Three Months Ended March 31, 2020

 

Major Goods/Service Line

 

Revenues from

Contracts with

Customers

  

Other Revenues

  

Total

 
             

Ethanol sales and related products, net

 $3,700  $  $3,700 

Hydrocarbon revenue

  125      125 
             
  $3,825  $  $3,825 

Timing of Revenue Recognition

            

Goods transferred at a point in time

 $3,825  $  $3,825 

Services transferred over time

         
             
  $3,825  $  $3,825 

 

  

Three Months Ended March 31, 2018

 

Major Goods/Service Line

 

Revenues from

Contracts with

Customers

  

Other Revenues

  

Total

 

Ethanol sales and related products, net

 $8,218     $8,218 

Hydrocarbon revenue

         

Grant and other revenue

  25      25 
  $8,243  $  $8,243 

Timing of Revenue Recognition

            

Goods transferred at a point in time

 $8,218  $  $8,218 

Services transferred over time

  25      25 
  $8,243  $  $8,243 

Operating Segment

            

Gevo

 $25  $  $25 

Gevo Development / Agri-Energy

  8,218      8,218 
  $8,243  $  $8,243 

Geographic Region

            

United States

 $8,243  $  $8,243 

Other

         
  $8,243  $  $8,243 
  

Three Months Ended March 31, 2019

 

Major Goods/Service Line

 

Revenues from

Contracts with

Customers

  

Other Revenues

  

Total

 
             

Ethanol sales and related products, net

 $5,664     $5,664 

Hydrocarbon revenue

  739      739 
             
  $6,403  $  $6,403 

Timing of Revenue Recognition

            
             

Goods transferred at a point in time

 $6,403  $  $6,403 

Services transferred over time

         
             
  $6,403  $  $6,403 

 

11
12

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

Goods transferred at a point-in-time. For the three monthsmonths ended March 31, 20192020 and 2018,2019, there were no contracts with customers for which consideration was variable or for which there were multiple performance obligations for any given contract. Accordingly, the entire transaction price is allocated to the goods transferred. As of March 31, 20192020 and December 31, 2018,2019, there were no remaining unfulfilled or partially fulfilled performance obligations.

 

All goods transferred are tested to ensure product sold satisfies contractual product specifications prior to transfer. The customer obtains control of the goods when title and risk of loss for the goods has transferred, which in most cases is “free-on-board, shipping point"point. All material contracts have payment terms of between one to three months and there are no return or refund rights.

 

Services transferred over time. For the three months ended March 31, 20192020 and 2018,2019, there were no contracts for which consideration was variable or for which there were multiple performance obligation for any given contract. Accordingly, the entire transaction price is allocated to the individual service performance obligation. As of March 31, 20192020 and December 31, 2018,2019, respectively, there were no material unfulfilled or partially fulfilled performance obligations.

For the three months ended March 31, 2019 and 2018, revenues were recognized ratably over time, as the performance obligation was satisfied and benefit to the customer was transferred on a ratable basis over time.

 

Contract Assets and Trade Receivables. As of March 31, 20192020 and December 31, 2018,2019, there were no contract assets or liabilities as all customer amounts owed to the Company are unconditional and the Company does not receive payment in advance for its products. Accordingly, amounts owed by customers are classified as account receivables on the Company’s consolidated balance sheets.Consolidated Balance Sheets. In addition, due to the nature of the Company’s contracts, there are no costs incurred or to be paid in the future that qualify for asset recognition as a cost to fulfill or obtain a contract. The Company did not incur any impairment losses on any receivables as all amounts owed were paid or current as of March 31, 2019 and2020 or December 31, 2018.2019.

 

 

4. Leases, Right-to-Use Assets and Related Liabilities

 

The Company enters into various arrangements which constitute a lease as defined by TopicAccounting Standards Codification ("ASC") 842, Leases, as part of its ongoing business activities and operations. Leases represent a contract or part of a contract that conveys the right to control the use of identified property, plant or equipment (an identified asset) for a period of time in exchange for consideration. Such contracts result in both (a) Right-to-useright-to-use assets, which represent the Company’s right to use an underlying asset for the term of the contract; and (b) a corresponding lease liability which represents the Company’s obligation to make the lease payments arising from the contract, measured on a discounted basis.

 

The contracts for the Company are comprised of facility, equipment and transportation leases necessary to conduct the Company’s day-to-day operations for which the Company maintains control of right-to-use assets and incurs the related liabilities.

The facility lease includes variable payments for common area maintenance. In addition, the Company elected to adopt both the (a) short-termhas one financing lease exemption for those leases with initial terms of twelve months or less; and (b) the practical expedient to not separate lease components from non-lease components, if applicable. Those leases which qualify for the short-term scope exception consist of certain residential rents for executive apartments, certain of the Company’s railcar leases, and otheroffice equipment leases. There were no leases containing variable lease payments, and none of the Company’s leases contained extension or termination options which were necessary in determining the value of the right-to-use asset and related liabilities. The Company assumed a 12.00% discount rate based, which is consistent with the stated rateincluded in "Loans payable - other" on the Company’s 2020 Notes (as defined below) and best approximation of the rate implicit in the Company’s leases.

Upon adoption of Topic 842 - Leases, the Company recognized a total of $1.2 million of right-to-use assets and related lease liabilities. Within the unaudited consolidated balance sheet at March 31, 2019, (i) $0.3 million of right-to-use assets with a remaining term of less than twelve months are included in Prepaid and other current assets, (ii) $0.5 million of right-to-use assets with a remaining term of exceeding twelve months are included in Deposits and other assets, and for the related lease liabilities, (iii) $0.6 million are included in Accounts payable and accrued liabilities for the current portion and (iv) $0.3 million are included in Other long-term liabilities for the non-current portion.Consolidated Balance Sheets.

 

There are two contractual agreements related to equipment improvements at the Luverne Facility that were not recognized as of March 31, 20192020 as a result of operating contingencies which must be satisfied before the Company is obligated under the terms of the contract. The total estimated fair value of unrecognized right-to-use assets and related lease liabilities relating to these contracts was approximately $3.0 million as of March 31, 2020 and December 31, 2019.

 

12
13

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

The following table presents the (a) costs by lease category and (b) other quantitative information relating to the Company’s leases.leases (dollars in thousands):

 

 

Three Months Ended

  

Three Months Ended

 
 

March 31, 2019

  March 31, 2020  

March 31, 2019

 

Lease Cost

            

Financing lease cost

 $-  $1  $ 

Operating lease cost

  345   471   345 

Short-Term lease cost

  17   13   17 

Variable lease cost

  -   32   33 

Sublease income

  - 
        

Total lease cost

 $362  $517  $395 
            

Other Information

            

(Gains) and losses on sale and leaseback transactions, net

 $- 

Cash paid for the measurement of lease liabilities

    

Operating cash flows from finance leases

  - 

Cash paid for the measurement of lease liabilities:

        
Operating cash flows from finance lease $1  $ 

Operating cash flows from operating leases

  345   471   345 

Financing cash flows from financing leases

    

Right-to-use assets obtained in exchange for new finance lease liabilities

  - 

Right-to-use assets obtained in exchange for new operating lease liabilities

  - 

Weighted-average remaining lease term, financing leases (months)

  - 
Right-to-use asset obtained in exchange for new financing lease liability 13   
Weighted-average remaining lease term, financing lease (months) 59   

Weighted-average remaining lease term, operating leases (months)

  19.60   18   20 

Weighted-average discount rate - financing leases

  -

%

Weighted-average discount rate - financing lease 21%  

Weighted-average discount rate - operating leases

  12.00

%

  12%  12

%

The table below shows the future minimum payments under non-cancelable financing and operating leases at March 31, 2020 (in thousands):

Year Ending December 31,

 

Financing Leases

  

Operating Leases

 
         

2020 (remaining)

 $3  545 

2021

  4   336 

2022

  4    
2023  4     
2024 and thereafter  5     

Total

  20   881 

Less: Amounts representing present value discounts

  (7) 

(64

)
         

Total lease liabilities

  13  

817

 

14

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

 

5. Inventories

 

The following table sets forth the components of the Company’s inventory balances (in thousands).:

 

 

March 31,

  

December 31,

  

March 31,

  

December 31,

 
 

2019

  

2018

  

2020

  

2019

 

Raw materials

                

Corn

 $92  $29  $14  $267 

Enzymes and other inputs

  145   204   155   184 

Finished goods

                
Jet Fuels, Isooctane and Isooctene 795  571 
Isobutanol 44  135 

Ethanol

  333   182      93 

Isobutanol

  457   549 

Jet Fuels, Isooctane and Isooctene

  306   394 

Distiller's grains

  40   54   8   54 

Work in process - Agri-Energy

  208   214 

Work in process - Gevo

  100   89 

Work in process

      

Agri-Energy

     254 

Gevo

  142   122 

Spare parts

  1,506   1,451   1,522   1,521 
        

Total inventories

 $3,187  $3,166  $2,680  $3,201 

 

Work in process inventory includes unfinished jet fuel, isooctane and isooctene inventory.

 

13
15

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

 

6. Property, Plant and Equipment

 

The following table sets forth the Company’s property, plant and equipment by classification (in thousands).:

 

 

Useful Life

  

March 31,

  

December 31,

  

Useful Life

  

March 31,

  

December 31,

 
 

(in years)

  

2019

  

2018

  

(in years)

  

2020

  

2019

 

Construction in progress

      $6,070  $3,478 
             
Luverne retrofit asset  20   $70,820  $70,820 

Plant machinery and equipment

  10    16,285   16,285   10    17,424   17,413 

Site improvements

  10    7,055   7,055   10    7,054   7,054 

Luverne retrofit asset

  20    70,842   70,842 

Lab equipment, furniture and fixtures and vehicles

  5    6,574   6,574   5    6,396   6,393 

Demonstration plant

  2    3,597   3,597   2    3,597   3,597 

Buildings

  10    2,543   2,543   10    2,543   2,543 

Leasehold improvements, pilot plant, land and support equipment

 2to5   2,523   2,523 

Computer, office equipment and software

  3    1,850   1,848  3to6   2,120   2,034 

Leasehold improvements, pilot plant, land and support equipment

  2to5   2,549   2,542 
Construction in progress       8,412   7,710 
           

Total property, plant and equipment

       117,365   114,764        120,889   120,087 

Less accumulated depreciation and amortization

       (49,320

)

  (47,728

)

       (55,034

)

  (53,391

)

             

Property, plant and equipment, net

      $68,045  $67,036       $65,855  $66,696 

 

Included in cost of goods sold isThe Company recorded depreciation of $1.6 million and $1.6 million during the three months ended March 31, 2019amortization expense related to property, plant and 2018, respectively. equipment as follows (in thousands):

 

 

 

Three Months Ended March 31,

 

 

 

2020

 

 

2019

 

 

 

 

 

 

 

 

 

 

Cost of goods sold

 

$

1,587 

 

$

1,560 

Operating expenses

 

 

56

 

 

 

52 

 

 

 

 

 

 

 

 

 

Total depreciation and amortization

 

$

1,643

 

 

$

1,612

 

Included in operating expenses is depreciation

16

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

 

7. Embedded Derivatives and Derivative Warrant Liabilities 

 

2020 Notes Embedded Derivative

 

In June 2017, the Company issued its 12% convertible senior secured notes due 2020 (the “2020 Notes”) in exchange for its 12.0% convertible senior secured notes due 2017 (the “2017 Notes”). The 2020 Notes containcontained the following embedded derivatives: (i) a Make-Whole Payment (as defined in the indenture governing the 2020 Notes (the “2020 Notes Indenture”)) upon either conversion or redemption; (ii) right to redeem the outstanding principal upon a Fundamental Change (as defined in the 2020 Notes Indenture); (iii) issuer rights to convert into a limited number of shares in any given three monththree-month period commencing nine months from the issuance date and dependent on the stock price exceeding 150% of the then in-effect conversion price over a ten-business day period; and (iv) holder rights to convert into either shares of the Company’s common stock or pre-funded warrants upon the election of the holders of the 2020 Notes.

 

Embedded derivatives are separated from the host contract and the 2020 Notes and carried at fair value when: (a) the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract; and (b) a separate, stand-alone instrument with the same terms would qualify as a derivative instrument. The Company has concluded that certain embedded derivatives within the 2020 Notes meet these criteria and, as such, must be valued separate and apart from the 2020 Notes as one embedded derivative and recorded at fair value each reporting period.

 

14

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

The Company used a binomial lattice model in order to estimate the fair value of the embedded derivative in the 2020 Notes. A binomial lattice model generates two probable outcomes, whether up or down, arising at each point in time, starting from the date of valuation until the maturity date. A lattice was initially used to determine if the 2020 Notes would be converted by the holder, called by the issuer, or held at each decision point. Within the lattice model, the following assumptions arewere made: (i) the 2020 Notes will be converted by the holder if the conversion value plus the holder’s Make-Whole Payment is greater than the holding value; or (ii) the 2020 Notes will be called by the issuer if (a) the stock price exceeds 150% of the then in-effect conversion price over a ten-business day period and (b) if the holding value is greater than the conversion value plus the Make-Whole Payment at the time.

 

Using this lattice model, the Company valued the embedded derivative using a “with-and-without method”, where the value of the 2020 Notes including the embedded derivative iswere defined as the “with”, and the value of the 2020 Notes excluding the embedded derivative is defined as the “without”. This method estimates the value of the embedded derivative by comparing the difference in the values between the 2020 Notes with the embedded derivative and the value of the 2020 Notes without the embedded derivative. The lattice model requires the following inputs: (i) price of Gevo common stock; (ii) Conversion Rate (as defined in the 2020 Notes Indenture); (iii) Conversion Price (as defined in the 2020 Notes Indenture); (iv) maturity date; (v) risk-free interest rate; (vi) estimated stock volatility; and (vii) estimated credit spread for the Company.

 

2020/21 Notes Embedded Derivative

In January 2020, the Company issued 12% convertible senior secured notes due 2020/2021 (the “2020/21 Notes”) in exchange for its 12.0% convertible senior secured notes due March 2020 (the “2020 Notes”). The 2020/21 Notes contain the following embedded derivatives: (i) a Make-Whole Payment (as defined in the 2020/21 Notes Indenture (as defined below) upon either conversion or redemption in certain circumstances; (ii) holder right to require the Company to repurchase the outstanding principal upon a Fundamental Change (as defined in the 2020/21 Notes Indenture); and (iii) holder rights to convert into either shares of the Company’s common stock or pre-funded warrants upon the election of the holders of the 2020/21 Notes.

Embedded derivatives are separated from the host contract and the 2020/21 Notes, and carried at fair value when: (a) the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract; and (b) a separate, stand-alone instrument with the same terms would qualify as a derivative instrument. The Company has concluded that certain embedded derivatives within the 2020/21 Notes meet these criteria and, as such, must be valued separate and apart from the 2020/21 Notes as one embedded derivative and recorded at fair value each reporting period.

The Company used a binomial lattice model in order to estimate the fair value of the embedded derivative in the 2020/21 Notes. Using this lattice model, the Company valued the embedded derivative using a “with-and-without method”.
GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

As of March 31, 2020 and December 31, 2019, the estimated fair value of the embedded derivatives was $0.1 million. Anymillion and $0, respectively. The change in the estimated fair value of the embedded derivatives represents an unrealized gain which has been(loss). The Company recorded as $0.2a $0.1 million loss from the change in fair value of 2020/21 Notes embedded derivatives and $0.2 million gain from the change in fair value of 2020 Notes embedded derivatives in the consolidated statements of operations for the three months ended March 31, 2020 and March 31, 2019, respectively. The Company recorded the estimated fair value of the embedded derivative with the 2020/21 Notes and 2020 Notes, net in the consolidated balance sheets.

Consolidated Balance Sheets.

The following table sets forth the inputs to the lattice modelmodels that were used to value the embedded derivatives.

derivatives:
  

March 31,

  

December 31,

 
  

2019

  

2018

 

Stock price

 $2.19   1.96 

Conversion Rate per $1,000

  67.95   67.95 

Conversion Price

 $14.72  $14.72 

Maturity date

 

March 15, 2020

  

March 15, 2020

 

Risk-free interest rate

  2.37%  2.57%

Estimated stock volatility

  120%  150%

Estimated credit spread

  26.8%  31%
  

March 31,

  January 10,  December 31, 
  

2020

  2020  2019 
             

Stock price

 $0.82  $2.27  $2.31 

Conversion Rate per $1,000

  409.50   409.50   67.95 

Conversion Price

 $2.44  $2.44  $14.72 

Maturity date

 

December 31, 2020

�� December 31, 2020  March 15, 2020 

Risk-free interest rate

  0.16%  1.52%  1.52%

Estimated stock volatility

  70%  40%  60%

Estimated credit spread

  40%  36%  27%

 

Changes in certain inputs into the lattice model can have a significant impact on changes in the estimated fair value of the embedded featured within the 2020/21 Notes and 2020 Notes. For example, the estimated fair value will generally decrease with: (1) a decline in the stock price; (2) decreases in the estimated stock volatility; and (3) a decrease in the estimated credit spread.

 

15

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

Derivative Warrant Liability

The following table sets forth information pertaining to shares issued upon the exercise of such warrants as of March 31, 2019:

  

Issuance

Date

 

Expiration

Date

 

Exercise

Price as of

March 31,

2019

  

Shares

Underlying

Warrants on

Issuance Date

  

Shares Issued

upon Warrant

Exercises as of

March 31, 2019

  

Shares

Underlying

Warrants

Outstanding as of

March 31,

2019 (1)

 

2014 Warrants

 

08/05/2014

 

08/05/2019

 $65.50   2,500   1,526   974 

Series A Warrants

 

02/03/2015

 

02/03/2020

 $3.80   5,542   5,222   320 

Series C Warrants

 

05/19/2015

 

05/19/2020

 $53.43   1,075      1,075 

Series D Warrants

 

12/11/2015

 

12/11/2020

 $40.00   25,125   25,078   47 

Series F Warrants

 

04/01/2016

 

04/01/2021

 $40.00   25,733   11,692   14,041 

Series I Warrants

 

09/13/2016

 

09/13/2021

 $220.00   35,650      35,650 

Series K Warrants

 

02/17/2017

 

2/17/2022

 $3.80   312,516   308,660   3,856 
           408,141   352,178   55,963 

(1)

This table does not include 6 equity-classified warrants issued between 2008 through 2012, with strike prices of $345 per share.

The agreements governing the above warrants include the following terms:

certain warrants have exercise prices which are subject to adjustment for certain events, including the issuance of stock dividends on the Company’s common stock and, in certain instances, the issuance of the Company’s common stock or instruments convertible into the Company’s common stock at a price per share less than the exercise price of the respective warrants;

warrant holders may exercise the warrants through a cashless exercise if, and only if, the Company does not have an effective registration statement then available for the issuance of the shares of its common stock. If an effective registration statement is available for the issuance of its common stock a holder may only exercise the warrants through a cash exercise;

the exercise price and the number and type of securities purchasable upon exercise of the warrants are subject to adjustment upon certain corporate events, including certain combinations, consolidations, liquidations, mergers, recapitalizations, reclassifications, reorganizations, stock dividends and stock splits, a sale of all or substantially all of the Company’s assets and certain other events; and

16

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

in the event of an “extraordinary transaction” or a “fundamental transaction” (as such terms are defined in the respective warrant agreements), generally including any merger with or into another entity, sale of all or substantially all of the Company’s assets, tender offer or exchange offer, or reclassification of its common stock, in which the successor entity (as defined in the respective warrant agreements) that assumes the successor entity is not a publicly traded company, the Company or any successor entity will pay the warrant holder, at such holder’s option, exercisable at any time concurrently with or within 30 days after the consummation of the extraordinary transaction or fundamental transaction, an amount of cash equal to the value of such holder’s warrants as determined in accordance with the Black-Scholes option pricing model and the terms of the respective warrant agreement. In some circumstances, the Company or successor entity may be obligated to make such payments regardless of whether the successor entity that assumes the warrants is a publicly traded company.

There were no warrants exercised during the three months ended March 31, 2019.

As of March 31, 2019, all of the Series B Warrants, Series E Warrants, Series G Warrants, Series H Warrants, Series J Warrants, Series L Warrants and Series M Warrants for which the exercise price had been adjusted were either fully exercised or expired.

 

 

8. Accounts Payable and Accrued Liabilities

 

The following table sets forth the components of the Company’s accounts payable and accrued liabilities in the consolidated balance sheets (in thousands).:

 

  

March 31,

  

December 31,

 
  

2019

  

2018

 

Accounts payable - trade

 $2,333  $1,944 

Accrued legal-related fees

  156   206 

Accrued employee compensation

  920   1,648 

Accrued interest

  344   - 

Accrued production fees

  297   255 

Accrued utilities and supplies payable

  284   344 

Accrued taxes payable

  197   101 

Current lease obligations

  577    

Other accrued liabilities *

  39   376 

Total accounts payable and accrued liabilities

 $5,147  $4,874 
  

March 31,

  

December 31,

 
  

2020

  

2019

 

 

        
Accrued utilities and supplies $1,393  $645 

Accounts payable - trade

  911   1,474 

Accrued employee compensation

  675   1,946 

Other accrued liabilities

  1,498   1,613 
         

Total accounts payable and accrued liabilities

 $4,477  $5,678 

*

Other accrued liabilities consist of franchise taxes, audit fees, and a variety of other expenses, none of which individually represent greater than five percent of total current liabilities.

 

17
18

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

 

9. Debt

 

2020 Notes and 2020/21 Notes

 

The following table sets forth information pertaining to the 2020 Notes and 2020/21 Notes which isare included in the Company’s consolidated balance sheets (in thousands).:

 

 

Principal

Amount

of 2020 Notes

  

Debt

Discount

  

Debt Issue

Costs

  

Total 2020

Notes

  

2020 Notes

Embedded

Derivative

  

Total 2020

Notes and 2020

Notes

Embedded

Derivative

  

Principal

Amount of

2020 Notes

  

Principal

Amount of

2020/21 Notes

  

Debt

Discount

  

Debt Issue

Costs

  

Total

Notes

  

 

Embedded

Derivative

  

Total

 

Balance - December 31, 2018

 $13,775  $(979

)

 $(242) $12,554  $394  $12,948 
                            

Balance - December 31, 2019

 $14,053  $  $(123

)

 $(30) $13,900  $  $13,900 
                            

Amortization of debt discount

     272      272      272         95      95      95 

Amortization of debt issue costs

        69   69      69            8   8      8 

Paid-in-kind interest

  69         69      69   47            47      47 

Change in fair value of 2020 Notes embedded derivative

              (246)  (246)

Balance - March 31, 2019

 $13,844  $(707

)

 $(173) $12,964  $148  $13,112 
Exchange of 2020 Notes for 2020/21 Notes  (14,100)  14,100                
Original issue discount paid with 2020/21 Notes     282   (282)            
Fair value of 2020/21 embedded derivative                 2,848   2,848 

Change in fair value of 2020/21 Notes embedded derivative

                 (2,748)  (2,748)
                            

Balance - March 31, 2020

 $  $14,382  $(310

)

 $(22) $14,050  $100  $14,150 

 

On April 19,June 20, 2017, the Company entered into an Exchange and Purchase Agreement (the “Purchase Agreement”) with WB Gevo, LTD, (the “Holder”), the holder of the 2017 Notes, which were issued under that certain Indenture dated as of June 6, 2014, by and among the Company, the guarantors party thereto, and Wilmington Savings Fund Society, FSB, as trustee and as collateral trustee (as supplemented, the “2017 Notes Indenture”), and Whitebox Advisors LLC, in its capacity as representative of the Holder (“Whitebox”). Pursuant to the terms of the Purchase Agreement, the Holder, subject to certain conditions, including approval of the transaction by the Company’s stockholders (which was received on June 15, 2017), agreed to exchange all of the outstanding principal amount of the 2017 Notes for an equal principal amount of the 2020 Notes in exchange for its 12.0% convertible senior secured notes due 2017 (the "2017 Notes"), plus an amount in cash equal to the accrued and unpaid interest (other than interest paid in kind) on the 2017 Notes (the “Exchange”). Pursuant to the Purchase Agreement, the Company also granted the Holder an option (the “Purchase Option”) to purchase up to an additional aggregate principal amount of $5.0 million of 2020 Notes (the “Option Notes”), at a purchase price equal to the aggregate principal amount of such Option Notes purchased, having identical terms (other than with respect to the issue date and restrictions on transfer relating to compliance with applicable securities law) to the 2020 Notes issued, at any time on or within ninety (90) days of the closing of the Exchange. The right to purchase Option Notes expired as of September 30, 2017. On June 20, 2017, the Company completed the Exchange, terminated the 2017 Notes Indenture and cancelled the 2017 Notes. The Company recognized an approximately $4.0 million loss which has been recorded as loss on exchange or conversion of debt within the consolidated statements of operations.

interest. The 2020 Notes will mature onhad a maturity date of March 15, 2020 and arewere secured by a first lien on substantially all of the Company’sour assets. The 2020 Notes bearhad an interest at a rate equal to 12% per annum (with 2% potentially payable as PIK Interest (as defined and described below) at the Company’sour option), payable on March 31, June 30, September 30 and December 31 of each year. To the extent that the Company paid any portion of the interest due on the 2020 Notes as PIK Interest, the maximum aggregate principal amount of the 2020 Notes that would have been convertible into shares of the Company's common stock increased.

Under certain circumstances, the Company hashad the option to pay a portion of the interest due on the 2020 Notes by either (a) increasing the principal amount of the 2020 Notes by the amount of interest then due or (b) issuing additional 2020 Notes with a principal amount equal to the amount of interest then due (interest paid in the manner set forth in (a) or (b) being referred to as “PIK Interest”). In the event the Company pays any portion of the interest due on the 2020 Notes as PIK Interest, the maximum aggregate principal amount of 2020 Notes that could be convertible into shares of the Company’s common stock will be increased.

Additional shares of the Company’sCompany's common stock maycould also have become issuable pursuant to the 2020 Notes in the event the Company iswas required to make certain make-whole payments as provided in the 2020 Notes Indenture.

 

The 2020 Notes arewere convertible into shares of the Company’sCompany's common stock, subject to certain terms and conditions. The initial conversion price of the 2020 Notes iswas equal to $14.72 per share of common stock, or 0.0679 shares of common stock per $1 principal amount of 2020 Notes.

19

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

2020/21 Notes

On January 10, 2020, the Company entered into an Exchange and Purchase Agreement (as amended, the “2020/21 Purchase Agreement”) with the guarantors party thereto (the "Guarantors"), the holder of the 2020 Notes and Whitebox Advisors LLC ("Whitebox"), in its capacity as representative of the holder. Pursuant to the terms of the 2020/21 Purchase Agreement, the holder of the 2020 Notes, subject to certain conditions, agreed to exchange all of the outstanding principal amount of the2020 Notes, which was approximately $14.1 million including unpaid accrued interest, for approximately $14.4 million in aggregate principal amount of the Company's newly created 2020/21 Notes (the “Conversion“2020/21 Exchange”).  Pursuant to the 2020/21 Purchase Agreement, the Company also granted an option to purchase up to an additional aggregate principal amount of approximately $7.1 million of 2020/21 Notes (the “2020/21 Option Notes”), at a purchase price equal to the aggregate principal amount of such 2020/21 Option Notes purchased less an original issue discount of 2.0%, having identical terms (other than with respect to the issue date and restrictions on transfer relating to compliance with applicable securities law) to the 2020/21 Notes issued, at any time during the period beginning on the date of closing of the 2020/21 Exchange and ending on the later of (a) 180 days thereafter, and (b) 30 days following the date on which Stockholder Approval (as described below) is obtained. In addition, on January 10, 2020, the Company completed the 2020/21 Exchange and cancelled the 2020 Notes. In addition, the Company entered into an Indenture by and among the Company, the guarantors named therein (the “2020/21 Notes Guarantors”) and FSB, as trustee and as collateral trustee (the “Original Indenture”), as supplemented by that certain First Supplemental Indenture, dated as of April 7, 2020 (the “First Supplemental Indenture” and, together with the Original Indenture, the “2020/21 Notes Indenture”), pursuant to which the Company issued the 2020/21 Notes. The Company recognized an approximately $0.7 million loss. See "(Loss) on modification of 2020 Notes" within the Consolidated Statements of Operations.

The 2020/21 Notes will mature on December 31, 2020, provided that the maturity date will automatically be extended to April 1, 2021 if (i) approval of a stockholder proposal is obtained prior to June 30, 2020 for the issuance of shares of the Company’s common stock under the 2020/21 Notes Indenture in excess of 19.99% of the outstanding shares of the Company’s common stock on the date of the Original Indenture (the “Stockholder Approval”), and (ii) the aggregate outstanding principal balance of the 2020/21 Notes (including any 2020/21 Option Notes) as of December 15, 2020 is less than $7 million. The 2020/21 Notes bear interest at a rate equal to 12% per annum (with 4% payable as PIK Interest (as defined and described below)), payable on March 31, June 30, September 30 and December 31 of each year. Under certain circumstances, the Company will have the option to pay a portion of the interest due on the 2020/21 Notes by either (a) increasing the principal amount of the 2020/21 Notes by the amount of interest then due or (b) issuing additional 2020/21 Notes with a principal amount equal to the amount of interest then due (interest paid in the manner set forth in (a) or (b) being referred to as “PIK Interest”). In the event the Company pays any portion of the interest due on the 2020/21 Notes as PIK Interest, the maximum aggregate principal amount of 2020/21 Notes that could be convertible into shares of the Company’s common stock will be increased.

The 2020/21 Notes are convertible into shares of the Company’s common stock at the conversion price, subject to certain terms and conditions. The initial conversion price of the 2020/21 Notes is equal to $2.442 per share of the Company’s common stock (the “2020/21 Notes Conversion Price”)., or 0.4095 shares of the Company’s common stock per $1 principal amount of 2020/21 Notes. The Company and the holders may also mutually agree on other conversions of the 2020/21 Notes into shares of the Company’s common stock on a monthly basis (a “Contractual Conversion”) pursuant to the terms of the 2020/21 Notes Indenture. The 2020/21 Notes Conversion Price in a Contractual Conversion will be reduced to the lesser of the then-applicable 2020/21 Notes Conversion Price or a 10% discount to the average of the daily volume weighted average price of the Company’s common stock for the three forward trading days prior to the date of the Contractual Conversion.

 

Each Holderholder has agreed not to convert its 20202020/21 Notes into shares of Companythe Company’s common stock to the extent that, after giving effect to such conversion, the number of shares of the Company’s common stock beneficially owned by such Holderholder and its affiliates would exceed 4.99% of Companythe Company’s common stock outstanding at the time of such conversion (the “4.99% Ownership Limitation”); provided that a Holderholder may, at its option and upon sixty-one (61)61 days’ prior notice to the Company, increase such threshold to 9.99% (the “9.99% Ownership Limitation”). If a conversion of 20202020/21 Notes by Whiteboxa holder would exceed the 4.99% Ownership Limitation or the 9.99% Ownership Limitation, as applicable, the 2020/21 Purchase Agreement contains a provision granting the holder a fully funded prepaid warrant for such common stock with a term of nine months, subject to a 6 monthsix-month extension, which it can draw down from time to time.

 

The 20202020/21 Notes may be redeemed in whole or in part, at the Company’s option, for cash at any time after the Stockholder Approval is obtained and upon 120 days’ notice to the holders of the 2020/21 Notes. A Redemption Make-Whole Payment (as defined in the 2020/21 Notes Indenture) applies only to a redemption of 2020/21 Notes that occurs on or after December 31, 2020. Following a notice of redemption of the 2020/21 Notes by the Company, the holders may elect to convert the 2020/21 Notes into shares of the Company’s common stock at the same conversion price as applicable to a Contractual Conversion.

20

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

The 2020/21 Notes do not contain any anti-dilution adjustments for future equity issuances that are below the 2020/21 Notes Conversion Price, and adjustments to the 2020/21 Notes Conversion Price will only generally be made in the event that there is a dividend or distribution paid on shares of the Company’s common stock, a subdivision, combination or reclassification of the Company’s common stock, or at the discretion of the Board of Directors of the Company in limited circumstances and subject to certain conditions.

 

The 2020/21 Notes are secured by a lien on substantially all of the assets of the Company and the 2020/21 Notes Guarantors, including intellectual property and real property, and are guaranteed by the Company’s existing subsidiaries.

Additional shares of the Company's common stock could also become issuable pursuant to the 2020/21 Notes in the event the Company is required to make certain make-whole payments as provided in the 2020/21 Notes Indenture.

Under certain circumstances, the Company may file one or more registration statements on Form S-3 or amend filings in order to register shares of common stock for sale or resale, as necessary in connection with the 20202020/21 Notes.

 

Loans Payable - Other

During the first quarter of 2020, the Company purchased equipment under a financing lease. During the fourth quarter 2019, the Company purchased equipment and financed part of its insurance obligation. The equipment notes and financing lease pay interest between 4% and 21%, have total monthly payments of $0.1 million and mature at various dates from August 2020 to February 2025. The equipment loans are secured by the related equipment. The balance of these loans at March 31, 2020 and December 31, 2019 are as follows (in thousands):

  March 31, 2020  December 31, 2019 
         
Equipment $318  $321 
Insurance  289   428 
         
Total notes payable - other  607   749 
Less current portion  (375)  (516)
         
Long-term portion $232  $233 

Future payments for Loans Payable - Other are as follows (in thousands):

Year ending December 31,    
     
2020 (remaining) $353 
2021  89 
2022  65 
2023  65 
2024 and thereafter  35 
     
  $607 

Small Business Administration Loans

In April 2020, the Company and Agri-Energy each entered into a loan agreement with Live Oak Banking Company, pursuant to which the Company and Agri-Energy obtained loans from the Small Business Administration's Paycheck Protection Program (“SBA PPP”) totaling $1.0 million in the aggregate (the "SBA Loans"). The SBA Loans will mature in April 2022 and bear interest at a rate equal to 1% per annum, subject to the potential for partial or full loan forgiveness as dictated by U.S. federal law. Principal and interest are deferred until November 2020 and interest continues to accrue during the deferral period. The SBA Loans are payable monthly beginning November 5, 2020, with aggregate payments totaling $0.06 million per month, including interest and principal. The SBA Loans must be used for payroll, rent payments, mortgage interest payments and utilities payments as governed by the SBA PPP and are subject to partial or full forgiveness for the initial eight-week period following the loan disbursement if all proceeds are used for eligible purposes and within certain thresholds, the Company maintains certain employment levels and the Company maintains certain compensation levels.

18
21

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

 

10.10. Equity Incentive Plans

2010 Stock Incentive Plan. In February 2011, the Company’s stockholders approved the Gevo, Inc. 2010 Stock Incentive Plan (as amended and restated to date, the "2010 Plan"). The 2010 Plan provided for the grant of non-qualified stock options, incentive stock options, stock appreciation rights, restricted stock awards, restricted stock units and other equity awards to employees and directors of the Company. On June 10, 2019, the 2010 Plan was amended and restated, which increased the number of shares of common stock reserved for issuance to 3,266,661 shares. In February 2020, the Company issued 109,337 shares of restricted common stock, vesting over three years, and 1,258 shares of restricted common stock, vesting over two years, to certain of its employees in relation to restricted stock awards granted on February 27, 2020. In April 2020, the Company also issued 239,155 shares of restricted common stock in relation to restricted stock awards granted to its employees on April 1, 2020 in connection with the 20% salary reduction discussed in Footnote 1, vesting on May 15, 2020. In March 2020, the Company withheld 4,055 shares of common stock to settle income taxes related to the vested restricted stock awards for certain employees. At March 31, 2020, an additional 1,679,947 shares were available for issuance upon the exercise of outstanding stock option awards or the grant of stock appreciation rights and restricted stock awards under the 2010 Plan.

Employee Stock Purchase Plan. In February 2011, the Company’s stockholders approved the Employee Stock Purchase Plan (the "ESPP"). The offering periods for the ESPP are from January 1 to June 30 and from July 1 to December 31 of each calendar year. The Company has reserved 190 shares of common stock for issuance under the ESPP, of which 190 shares as of March 31, 2020 are available for future issuance. The purchase price of the common stock under the ESPP is 85% of the lower of the fair market value of a share of common stock on the first or last day of the purchase period. There were no purchases of common stock under the ESPP during the three months ended March 31, 2020 or 2019.

22

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

11. Stock-Based Compensation

 

The Company records stock-based compensation expense during the requisite service period for share-based payment awards granted to employees and non-employees.

 

The following table sets forth the Company’s stock-based compensation expense (in thousands) for the periods indicated.

 

 

Three Months Ended March 31,

  

Three Months Ended March 31,

 
 2019  

2018

  2020  

2019

 

Stock options and employee stock purchase plan awards

        

Research and development

 $  $10 

Selling, general and administrative

     30 
         

Restricted stock

                

Research and development

  28   17  $76  $28 
Selling, general and administrative 206  41  260  206 
            
Stock appreciation rights            
Research and development 16    (79) 16 

Selling, general and administrative

  13      (85)  13 
       

Total stock-based compensation

 $263  $98  $172  $263 

Stock Option Award Activity. Stock option activity under the Company’s stock incentive plans at March 31, 2020 and changes during the three months ended March 31, 2020 were as follows.

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

 

 

 

 

 

 

 

 

 

Weighted-

 

 

Remaining

 

 

 

 

 

 

 

 

 

 

 

Average

 

 

Contractual

 

 

Aggregate

 

 

 

Number of

 

 

Exercise

 

 

Term

 

 

Intrinsic

 

 

 

Options

 

 

Price

 

 

(years)

 

 

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding at December 31, 2019

 

 

1,561

 

 

$

928.79

 

 

 

6.56

 

 

$

 

Granted

 

 

 

 

$

 

 

 

 

 

 

 

 

 

Canceled or forfeited

 

 

 

 

$

 

 

 

 

 

 

 

 

 

Exercised

 

 

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options outstanding at March 31, 2020

 

 

1,561

 

 

$

928.79

 

 

 

6.31

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options exercisable at March 31, 2020

 

 

1,561

 

 

$

928.79

 

 

 

6.31

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options vested and expected to vest at March 31, 2020

 

 

1,561

 

 

$

928.79

 

 

 

6.31

 

 

$

 

Restricted Stock. Non-vested restricted stock awards at March 31, 2020 and changes during the three months ended March 31, 2020 were as follows.

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

Average

 

 

 

Number of

 

 

Grant-Date

 

 

 

Shares

 

 

Fair Value

 

 

 

 

 

 

 

 

 

 

Non-vested at December 31, 2019

 

 

1,308,613

 

 

$

1.91 

Granted

 

 

110,595

 

 

$

1.51

 

Vested

 

 

(19,153

)

 

$

1.87

 

Canceled or forfeited

 

 

(6,974

)

 

$

1.90

 

 

 

 

 

 

 

 

 

 

Non-vested at March 31, 2020

 

 

1,393,081

 

 

$

1.83 

The total fair value of restricted stock that vested during the three months ended March 31, 2020 totaled $0.3 million. As of March 31, 2020, the total unrecognized compensation expense, net of estimated forfeitures, relating to restricted stock awards was $1.7 million, which is expected to be recognized over the remaining weighted-average period of approximately 1.2 years.

23

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

 

11.12. Commitments and Contingencies

 

Legal Matters. From time to time, the Company has been, and may again become, involved in legal proceedings arising in the ordinary course of its business. The Company is not presently a party to any litigation that it believes to be material and is not aware of any pending or threatened litigation against the Company that it believes could have a material adverse effect on its business, operating results, financial condition or cash flows.

 

Leases. Upon adoption of ASU 2016-02, the Company identified three lease agreements that qualify as “operating” based on the terms and conditions at the commencement date for each lease. These include the lease for the Company’s office and research facility in Englewood, Colorado, with a term expiring in July 2021 and leases of plant equipment and transportation equipment with expiration dates in June 2019 used by Agri-Energy at the Luverne Facility.

All other leases qualified for the short-term scope exemption. These consist of corporate apartments in Colorado, which have initial lease terms of less than twelve months, and additional leases of transportation equipment located both at the Luverne Facility and the South Hampton Facility with original lease terms of less than twelve months.

Rent expense for the three months ended March 31, 2019 and 2018 was $0.4 million and $0.4 million, respectively.

The table below shows the future minimum payments under non-cancelable short-term and operating leases and at March 31, 2019 (in thousands):

  Short-Term Leases   

Operating

Leases

 

2019 (remaining)

$406  $613 

2020

 233   422 

2021

    218 

2022

     

2023 and thereafter

     

Total

$639  $1,253 

19

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

The Company entered into a five-year software licensing agreement on April 2, 2018 with future contractual payment obligations totaling approximately $0.6 million. This licensing agreement is accounted for as an intangible asset and is out of the scope of ASU 2016-02 - Leases. 

Indemnifications. In thethe ordinary course of its business, the Company makes certain indemnities under which it may be required to make payments in relation to certain transactions. As of March 31, 20192020 and December 31, 2018,2019, the Company did not have any liabilities associated with indemnities.

Certain of the Company’s financial instruments consist of cash and cash equivalents, accounts receivable, and accounts payable, for which the carrying value on the Company’s balance sheet approximates their fair values due to the short maturities.

 

In addition, the Company, as permitted under Delaware law and in accordance with its amended and restated certificate of incorporation and amended and restated bylaws, in each case, as amended to date, indemnifies its officers and directors for certain events or occurrences, subject to certain limits, while the officer or director is or was serving at the Company’s request in such capacity. The duration of these indemnifications, commitments, and guarantees varies and, in certain cases, is indefinite. The maximum amount of potential future indemnification is unlimited; however, the Company has a director and officer insurance policy that may enable it to recover a portion of any future amounts paid. The Company accrues for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable. No such losses have been recorded to date.

 

Environmental Liabilities. The Company’s operations are subject to environmental laws and regulations adopted by various governmental authorities in the jurisdictions in which it operates. These laws require the Company to investigate and remediate the effects of the release or disposal of materials at its locations. Accordingly, the Company has adopted policies, practices and procedures in the areas of pollution control, occupational health and the production, handling,handling, storage and use of hazardous materials to prevent material environmental or other damage, and to limit the financial liability which could result from such events. Environmental liabilities are recorded when the Company’s liability is probable and the costs can be reasonably estimated. No environmental liabilities have been recorded as of March 31, 2019 or December 31, 2018.2020.

24

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

 

12.13. Fair Value Measurements

 

Accounting standards define fair value, outline a framework for measuring fair value, and detail the required disclosures about fair value measurements. Under these standards, fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date in the principal or most advantageous market. Standards establish a hierarchy in determining the fair market value of an asset or liability. The fair value hierarchy has three levels of inputs, both observable and unobservable. Standards require the utilization of the highest possible level of input to determine fair value.

 

Level 1 – inputs include quoted market prices in an active market for identical assets or liabilities.

 

Level 2 – inputs are market data, other than Level 1, that are observable either directly or indirectly. Level 2 inputs include quoted market prices for similar assets or liabilities, quoted market prices in an inactive market, and other observable information that can be corroborated by market data.

 

Level 3 – inputs are unobservable and corroborated by little or no market data.

 

20
25

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

 These tables present the carrying value and fair value, by fair value hierarchy, of our financial instruments, excluding cash and cash equivalents, accounts receivable and accounts payable, which approximate fair value due to their short-term nature, at March 31, 20192020 and December 31, 2018,2019, respectively (in thousands).:

 

     

Fair Value Measurements at March 31, 2019

(In thousands)

      

Fair Value Measurements at March 31, 2020

(In thousands)

 
 

Fair Value at

March 31,

2019

  

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

  

Significant Other

Observable Inputs

(Level 2)

  

Significant

Unobservable

Inputs (Level 3)

  

Fair Value at

March 31,

2020

  

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

  

Significant Other

Observable Inputs

(Level 2)

  

Significant

Unobservable

Inputs (Level 3)

 

Recurring:

                                

Derivative Warrant Liability

 $21  $  $  $21  $1  $  $  $1 

2020 Embedded Derivative Liability

  148         148 

2020/21 Notes Embedded Derivative Liability

  100         100 

Total Recurring Fair Value Measurements

 $169  $  $  $169  $101  $  $  $101 
                                
                                

Nonrecurring

                                

Corn and finished goods inventory

 $1,179  $92  $1,087  $  $387  $14  $373  $ 

Total Non-Recurring Fair Value Measurements

 $1,179  $92  $1,087  $ 

 

     

Fair Value Measurements at December 31, 2018

(In thousands)

      

Fair Value Measurements at December 31, 2019

(In thousands)

 
 

Fair Value at

December 31,

2018

  

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

  

Significant Other

Observable Inputs

(Level 2)

  

Significant

Unobservable

Inputs (Level 3)

  

Fair Value at

December 31,

2019

  

Quoted Prices in

Active Markets for

Identical Assets

(Level 1)

  

Significant Other

Observable Inputs

(Level 2)

  

Significant

Unobservable

Inputs (Level 3)

 

Recurring:

                                

Derivative Warrant Liability

 $22  $  $  $22  $8  $  $  $8 

2020 Embedded Derivative Liability

  394         394 

Total Recurring Fair Value Measurements

 $416  $  $  $416 
                                
                                

Nonrecurring

                                

Corn and finished goods inventory

 $1,047  $29  $1,018  $  $940  $267  $673  $ 

Total Non-Recurring Fair Value Measurements

 $1,047  $29  $1,018  $ 

 

21
26

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

The following table provides changes to those fair value measurements using Level 3 inputs for the three months ended March 31, 2019.2020 (in thousands):

 

  

Fair Value Measurements Using Significant Unobservable Inputs

(Level 3) (in thousands)

 
         
  

Derivative Warrant

Liability

  

2020 Notes Embedded

Derivative

 

Opening Balance

 $22  $394 

Transfers into Level 3

      

Transfers out of Level 3

      

Total (gains) or losses for the period

        

Included in earnings

  (1

)

  (246

)

Included in other comprehensive income

      

Purchases, issues, sales and settlements

        

Purchases

      

Issues

      

Sales

      

Settlements

      

Closing balance

 $21  $148 
  

Fair Value Measurements Using Significant Unobservable Inputs

(Level 3)

 
         
  

Derivative Warrant

Liability

  

2020/21 Notes Embedded

Derivative

 
         

Balance, December 31, 2019

 $8  $ 
         
Issue of 2020/21 Notes embedded derivative liability     2,848 

Total (gains) included in earnings

  (7)  (2,748)
         
Balance, March 31, 2020 $1  $100 

There were no transfers to or from Level 3 in the three months ended March 31, 2020.

 

Inventories. The Company records its corn inventory at fair value only when the Company’s cost of corn purchased exceeds the market value for corn. The Company determines the market value of corn and dry distiller’s grain based upon Level 1 inputs using quoted market prices. The Company records its ethanol, isobutanol and hydrocarbon inventory at market using Level 2 inputs.

 

20202020/21 Notes Embedded Derivative. The Company had estimated the fair value of the embedded derivative on a stand-alone basis to be $0.1 million at March 31, 2019 and $0.45 million at December 31, 20182020 based upon Level 3 inputs. Changes in the fair value of the embedded derivative is recognized each reporting period as a “Change in fair value of 20202020/21 Notes embedded derivative” in the consolidated Statements of Operations and Statements of Cash Flows. See Note 6, 7, Embedded Derivatives and Derivative Warrant Liabilities,, for the fair value inputs used to estimate the fair value of the embedded derivative.

 

Derivative Warrant Liability. Prior to 2017, the Company estimated the fair value of the Series A Warrants, Series F Warrants and Series K Warrants using a Monte- Carlo model (Level 3). For all other warrants the Company valued these using a standard Black-Scholes model (Level 2). However, beginning in the first quarter 2017, the Company valued the Series F Warrants and Series K Warrants using a Monte-Carlo model (Level 3) and other warrants using Black-Scholes models comprised of some inputs requiring the use of Monte-Carlo models (Level 3). The Company has estimated the fair value of the derivative warrant liability to be $0.02 million as of March 31, 2019 and  December 31, 2018.

While the Company believes that its valuation methods are appropriate and consistent with other market participants, it recognizes that the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

 

 

13.14. Segments

 

The Company has determined that it has two operating segments: (i) Gevo segment; and (ii) Gevo Development/Agri-Energy segment. The Company organizes its business segments based on the nature of the products and services offered through each of its consolidated legal entities. Transactions between segments are eliminated in consolidation.

 

Gevo Segment. The Gevo segment is responsible for all research and development activities related to the future production of isobutanol, including the development of our proprietary biocatalysts, the production and sale of bio jet fuel, the Company’s retrofit process and the next generation of chemicals and biofuels that will be based on the Company’s isobutanol technology. The Gevo segment also develops, maintains and protects its intellectual property portfolio, develops future markets for its isobutanol and provides corporate oversight services.

 

22
27

 

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

 

Gevo Development/Agri-Energy Segment. The Gevo Development/Agri-Energy segment is currently responsible for the operation of the Company’s Luverne Facility and the production of ethanol, isobutanol and related products.

 

The Company’s chief operating decision maker is provided with and reviews the financial results of each of the Company’s consolidated legal entities, Gevo, Inc., Gevo Development, LLC and Agri-Energy, LLC. The Company organizes its business segments based on the nature of the products and services offered through each of its consolidated legal entities. All revenue is earned and all assets are held in the U.S.

 

Three Months Ended March 31,

  

Three Months Ended March 31,

 
 2019  

2018

  2020  

2019

 

Revenues:

                

Gevo

 $739  $25  $125  $739 

Gevo Development / Agri-Energy

  5,664   8,218   3,700   5,664 
       

Consolidated

 $6,403  $8,243  $3,825  $6,403 
                

Loss from operations:

                

Gevo

 $(2,673) $(2,476

)

 $(2,881) $(2,673

)

Gevo Development / Agri-Energy

  (2,955)  (2,523

)

  

(5,095

)  (2,955

)

       

Consolidated

 $(5,628) $(4,999

)

 $

(7,976

) $(5,628

)

                

Interest expense:

                

Gevo

 $755  $825  $543  $755 

Gevo Development / Agri-Energy

  

      

2

    
       

Consolidated

 $755  $825  $545  $755 
                

Depreciation expense:

        

Depreciation and amortization expense:

        

Gevo

 $51  $84  $56  $51 

Gevo Development / Agri-Energy

  1,561   1,562   1,593   1,561 
       

Consolidated

 $1,612  $1,646  $1,649  $1,612 
                

Acquisitions of plant, property and equipment:

                

Gevo

 $2,204  $  $10  $2 

Gevo Development / Agri-Energy

  -   67   791   2,202 
       

Consolidated

 $2,204  $67  $801  $2,204 
       
Revenue by geographic area       
United States $3,750  $5,664 
Other  75   739 
       
Consolidated $3,825  $6,403 

 

  

March 31,

 
  2019  

2018

 

Total assets:

        

Gevo

 $109,312  $81,629 

Gevo Development / Agri-Energy

  142,985   147,290 

Intercompany eliminations

  (140,834)  (146,046

)

Consolidated

 $111,463  $82,873 

14. Subsequent Events

None noted for the unaudited consolidated financial statements for the quarter ended March 31, 2019.

23
28

GEVO, INC.

Notes to Consolidated Financial Statements

(unaudited)

  March 31,  December 31, 
  2020  

2019

 
         

Total assets

        

Gevo

 $80,279  $91,861 

Gevo Development / Agri-Energy

  140,293   143,349 

Intercompany eliminations (1)

  (136,410)  (141,851

)

         

Consolidated (2)

 $84,162  $93,359 

(1)

Includes intercompany sales of $0.1 million during the three months ended March 31, 2020 and $0.4 million for the year ended December 31, 2019 for hydrocarbon sales.

(2)

All other significant non-cash items relate to the activities of Gevo.

 

29

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Forward-Looking Statements

 

This Quarterly Report on Form 10-Q (this “Report”) contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). When used anywhere in this Report, the words “expect,” “believe,” “anticipate,” “estimate,” “intend,” “plan” and similar expressions are intended to identify forward-looking statements. These statements relate to future events or our future financial or operational performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievements to differ materially from those expressed or implied by these forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to risks and uncertainties. These forward-looking statements include, among other things, statements about: the impact of the novel coronavirus ("COVID-19") pandemic to our business, our financial condition, our results of operation and liquidity, risks and uncertainties related to our ability to sell our products, our ability to expand or continue production of ethanolisobutanol, renewable hydrocarbon products and isobutanolethanol at our production facility in Luverne Minnesota (the “Luverne Facility”), our ability to meet our production, financial and operational guidance, our strategy to pursue low-carbon ethanolrenewable fuels for sale into California and elsewhere, our ability to replace our fossil-based energy sources with renewable energy sources at the Luverne Facility and elsewhere, our ability and plans to construct a commercial hydrocarbon facility to produce renewable isooctane and alcohol-to-jet fuel (“ATJ”("ATJ"), our ability to raise additional funds to continue operations and/or expand our production capabilities, our ability to perform under our existing renewable hydrocarbon offtake agreements and other supply agreements we may enter into in the Luverne Facility,future, our ability to enter into additional hydrocarbon supply agreements, our ability to obtain project finance debt and third-party equity for our renewable natural gas project, our ability to produce ethanolisobutanol, renewable hydrocarbon products and isobutanolethanol on a commercial level and at a profit, achievement of advances in our technology platform, the success of our retrofitupgraded production model,facility, the availability of suitable and cost-competitive feedstocks, our ability to gain market acceptance for our products, the expected cost-competitiveness and relative performance attributes of our ethanolisobutanol, renewable hydrocarbon products and isobutanol and the products derived from isobutanol,ethanol, additional competition and changes in economic conditions and the future price and volatility of petroleum and products derived from petroleum. Important factors could cause actual results to differ materially from those indicated or implied by forward-looking statements such as those contained in documents we have filed with the U.S. Securities and Exchange Commission (the “SEC”), including this Report in Item 2.7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” our Annual Report on Form 10-K for the year ended December 31, 20182019 (our “Annual Report”), and subsequent reports on Form 10-Q.10-Q, including Item 1A. "Risk Factors" of this Report. All forward-looking statements in this Report are qualified entirely by the cautionary statements included in this Report and such other filings. These risks and uncertainties could cause actual results to differ materially from results expressed or implied by forward-looking statements contained in this Report. These forward-looking statements speak only as of the date of this Report. We undertake no intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, and readers should not rely on the forward-looking statements as representing the Company’s views as of any date subsequent to the date of the filing of this Report.

 

Unless the context requires otherwise, in this Report the terms “we,” “us,” “our” and the “Company” refer to Gevo, Inc. and its subsidiaries.

 

The following discussion should be read in conjunction with our unaudited consolidated financial statements and the related notes and other financial information appearing elsewhere in this Report. Readers are also urged to carefully review and consider the various disclosures made by us which attempt to advise interested parties of the factors which affect our business, including, without limitation, the disclosures in our Annual Report.

 

Reverse Stock Split

On June 1, 2018, we effected a reverse stock split of the outstanding shares of our common stock by a ratio of one-for-twenty (the “Reverse Stock Split”) and our common stock began trading on the Nasdaq Capital Market on a Reverse Stock Split-basis on June 4, 2018.  Unless otherwise indicated, all share amounts, per share data, share prices, exercise prices and conversion rates set forth herein have, where applicable, been adjusted retroactively to reflect the Reverse Stock Split.

Company Overview

 

We are a growth-oriented renewable fuels company that is commercializing the next generation “low-carbon” fuel company focused on the development and commercialization of renewable alternatives to petroleum-based products. Low-carbonlow-carbon liquid transportation fuels reduce the carbon intensity, or the level of greenhouse gas emissions, compared to standard fossil-based fuels across their lifecycle. The most common low-carbon fuels are renewable fuels. We are focused on the development and production of mainstream fuels like jet fuel and gasoline using renewable feedstocks that havewith the potential to lowerachieve “net zero” greenhouse gas (“GHG”) footprint and address global needs of reducing GHG emissions at a meaningful scalewith sustainable alternatives to petroleum fuels. As next generation renewable fuels, our hydrocarbon transportation fuels have the advantage of being “drop-in” substitutes for conventional fuels that are derived from crude oil, working seamlessly and enhance agricultural production, including foodwithout modification in existing fossil-fuel based engines, supply chains and other related products.storage infrastructure. In addition to the potential of net zero carbon emissions across the whole of the fuel life-cycle, our renewable fuels eliminate other pollutants associated with the burning of traditional fossil fuels such as particulates and sulfur, while delivering superior performance. We believe that the world is substantially under-supplied with low-carbon, drop-in renewable fuels that can be immediately used in existing transportation engines and infrastructure, and we are uniquely positioned to grow in serving the low-carbon fuel markets, we can also serve markets for the production of chemical intermediate products for solvents, plastics, and building block chemicals using our technologies.that demand.

 

Our production processes and fuel products have been proven to work. We use low-carbon, renewable resource-based carbohydrates as raw materials. In the near-term, our feedstocks will primarily consist of non-food corn. As our technology is applied globally, feedstocks can consist of sugar cane, molasses or other cellulosic sugars derived from wood, agricultural residues and waste. Our patented fermentation yeast biocatalyst produces isobutanol, a four-carbon alcohol, via the fermentation of renewable plant biomass carbohydrates. The resulting renewable isobutanol has a variety of direct applications but, more importantly to our fundamental strategy, serves as a building block to make renewable gasoline and jet fuel using simple and common chemical conversion processes. We also plan to reduce or eliminate fossil-based process energy inputs by replacing them with renewable energy such as wind-powered electricity and renewable natural gas (“RNG”).

30

COVID-19

The COVID-19 pandemic has had an adverse impact on global commercial activity, including the global transportation industry and its supply chain, and has contributed to significant volatility in the financial markets including, among other effects, a decline in the equity markets and reduced liquidity generally for many companies, including us. In light of the potential future disruption to our own business operations and those of our customers, suppliers and other third parties with whom we interact, we considered the impact of the COVID-19 pandemic on our business. This analysis considered our business' resilience and continuity plans, financial modeling and stress testing of liquidity and financial resources.

The analysis concluded that the COVID-19 pandemic did not have a material adverse impact to our financial results for the first quarter of 2020. Although the COVID-19 pandemic did not have a material adverse impact to our financial results for the first quarter of 2020, we expect that the impact of the COVID-19 pandemic on general economic activity could negatively impact our revenue and operating results for the remainder of 2020. For example, in March 2020, following a temporary suspension of ethanol production technologies target whatat the Luverne Facility, we ultimately suspended production for the foreseeable future due to the impact of COVID-19 on the economy and our industry as a whole. There is also a risk that COVID-19 could have a material adverse impact on customer demand and cash flow for the remainder of 2020 and beyond. We will continue to monitor the situation and assess possible implications to our business and our stakeholders and will take appropriate actions to help mitigate adverse consequences. The extent to which COVID-19 impacts our business and financial position will depend on future developments, which are difficult to predict, including the severity, duration and scope of the COVID-19 outbreak as well as the types of measures imposed by governmental authorities to contain the virus or address its impact and the duration of those actions and measures.

We have considered multiple scenarios, with both positive and negative inputs, as part of the significant estimates and assumptions that are inherent in our financial statements and are based on trends in customer behavior and the economic environment throughout the quarter and beyond as the COVID-19 pandemic has impacted the industries in which we operate. These estimates and assumptions include the collectability of billed and unbilled receivables, the estimation of revenue and tangible and intangible assets. With regard to collectability, we believe to be large potential markets of renewable fuels and related chemicals that can compete directly against petrochemical products depending on the price of oil and the value of carbon intensity reductions. Renewable fuels are one of the few fuel products where the value for renewable carbon has already been established, particularlywe may face atypical delays in the United States and the European Union. Weclient payments going forward. In addition, we believe that the demand for low-carbon fuelscertain discretionary lines of business may decrease, and that such decrease will impact our financial results in succeeding periods. Non-discretionary lines of business may also be adversely affected, for example because reduced economic activity or disruption in hydrocarbon markets reduces demand for or the extent of ATJ, isooctane and isooctene. We believe that these trends and uncertainties are comparable to those faced by other registrants as a result of the pandemic.

In response to the impact of the COVID-19 pandemic, we reduced our workforce in March 2020, impacting 26 people at the Luverne Facility and four people at our corporate headquarters. (See "Restructuring Expenses" below.) We also reduced, and each of Patrick R. Gruber, our Chief Executive Officer, Christopher M. Ryan, our President, Chief Operating Officer and Chief Technology Officer, L. Lynn Smull, our Chief Financial Officer, Timothy J. Cesarek, our Chief Commercial Officer, Geoffrey T. Williams, Jr., our General Counsel and Secretary, and Carolyn M. Romero, our Vice President - Controller and Principal Accounting Officer (collectively, the “Officers”) accepted 20% reductions to their base salaries. These reductions became effective as of April 1, 2020 for a period of 90 days thereafter. In connection with the 20% salary reduction, the Officers were granted Company stock in the form of restricted stock awards in an amount equal to the 20% reduction. Certain remaining employees that earn above a certain dollar threshold also agreed to take a 20% salary reduction over the next three months, with the 20% portion to be paid in the form of restricted stock awards.

In addition, in connection with the impact that the COVID-19 pandemic has had on the economy and on the resulting disruption to the airline industry specifically, we and Delta Air Lines, Inc. (“Delta”) amended portions of our previously disclosed Fuel Sales Agreement (the “Delta Agreement”) on April 22, 2020 (the “Delta Amendment”). The Delta Amendment provides that Delta may terminate the Delta Agreement if we do not notify Delta by June 30, 2024 that the facility for the production, refining and delivery of ATJ with a nameplate capacity of up to 12 million gallons per year (the “Facility”) has achieved commercial operation and the ability to produce and deliver the ATJ purchased pursuant to the Delta Agreement (the date upon which such operation occurs is referred to as the “Commencement Date”).

The Delta Amendment also revises the credit support terms in the Delta Agreement to state that we and Delta will work to mutually agree upon credit support terms for the take or pay that are acceptable to our lender to enable us to obtain third party financing prior to the earlier of the time that we obtain financing for construction of the Facility or otherwise issue a notice to commence construction of the Facility. If we and Delta are unable to agree on reasonable credit support terms, we may terminate the Delta Agreement. The balance of Delta’s credit support obligations were deleted.

In addition, the Delta Amendment revises the ATJ pricing in the Delta Agreement to the extent that if Brent Crude is below a certain cutoff price as of the date that is 60 days prior to the Commencement Date (the “Commencement Notice Date”), then the pricing adjusts based upon a formula related to the Brent crude prices as of the Commencement Notice Date. The Delta Amendment also provides that, if as of the Commencement Notice Date, the Brent Crude price is below the price adjustment range, Delta may eliminate the take-or-pay requirements of the Delta Agreement, which includes eliminating Delta’s obligation to take-or-pay the 10 million gallons per year of ATJ. Instead, the Delta Agreement would require us and Delta to agree at that time on the volumes and price of any ATJ to be sold under the Delta Agreement.

Restructuring Expenses

During the first quarter of 2020, we temporarily suspended and ultimately suspended for the foreseeable future our ethanol production at the Luverne Facility. In addition, due to the impact of the COVID-19 pandemic on the global economy and our industry, we also reduced our workforce impacting 26 people at the Luverne Facility and four people at our corporate headquarters. Affected employees were offered a severance package which included a one-time payment, one month of health insurance and acceleration of vesting of any unvested restricted stock awards.

We incurred $0.1 million related to severance costs and $0.2 million related to lease agreements for which it will no longer receive value during the three months ended March 31, 2020, which are recorded as Restructuring expenses on the Consolidated Statements of Operations.

We intend to continue developing our hydrocarbon business, including the planned expansion of the Luverne Facility, and we expect to move forward in securing the project funding needed to expand the Luverne Facility. The expansion is designed to allow us to produce large quantities of low carbon isobutanol, sustainable aviation fuel and renewable chemicals willisooctane. We also expect to continue to grow inengineering efforts for the future.expansion of isobutanol production and the construction of a commercial renewable hydrocarbon production facility, as well as additional decarbonization projects, at the Luverne Facility.

 

Latest Highlights and Developments

On April 4, 2019, we executed a binding, definitive Construction License Agreement with Praj Industries Ltd. (“ Praj”), pursuant to which we will commercialize the production of renewable isobutanol using sugary-based feedstocks, such as juice, syrup and molasses made of sugarcane and sugar beets (the “Construction License Agreement”). Pursuant to the Construction License Agreement, Praj will provide engineering procurement and construction services to certain third party customers using a process design package that incorporates our proprietary isobutanol biocatalyst and is designed for use with sugary-based feedstocks (the “PDP”). The PDP is jointly owned by us and Praj. We have granted a license to Praj that would allow Praj to provide such services to certain third party customers. In connection with the Construction License Agreement, Gevo and Praj have also entered into a new Joint Development Agreement and a new Development License Agreement, dated April 4, 2019, to continue their joint development efforts to produce isobutanol using sugarcane juice, sugarcane syrup, sugarcane molasses, sugar beet juice, sugar beet syrup, sugar beet molasses, sugar beet pulp, cassava, rice, wheat, sorghum, bagasse, rice straw, wheat straw, corn stover, cotton stalk and empty fruit bunches.
On April 4, 2019, we also executed a Memorandum of Understanding (“MOU”) with Praj Industries Ltd. to commercialize our renewable hydrocarbon products in India, including our ATJ and renewable isooctane, derived from our renewable isobutanol. The MOU contemplates two phases.  In phase one, Praj will implement a pilot plant in India for the purpose of introducing our technology to potential customers.  Following phase one, we expect to enter into a commercial license agreement for the production of renewable hydrocarbons. Together, we expect to use a combination of their respective technologies for the conversion of sugars to renewable hydrocarbon products.
24
31

Luverne Facility Update

As previously announced, we are undertaking several initiatives to improve the profitability of the Luverne Facility. Specifically, we are adapting and optimizing the Luverne Facility’s energy and equipment infrastructure to use lower amounts of lower fossil-based energy sources to lower the carbon intensity score of our products and decrease our production costs. We are also installing a process, the Shockwave Process, to fractionate corn to enable more feed and food products to be sold from the Luverne Facility that should increase revenues and profitability at the Luverne Facility. The Shockwave Process is expected to be operational during the first half of 2019. In addition, we are currently evaluating the implementation of one or more of the following systems or technologies to further lower our use of fossil-based energy sources at the Luverne Facility: combined heat and power systems; manure biogas, wind power and certain other expansion and energy reduction technologies. We expect that by approximately the end of 2020 we will have completed certain projects at our Luverne Facility to improve the carbon intensity score of our products that will increase the value of our ethanol and related products and that should translate into increased revenues for us as a result of the credits associated with our renewable fuels under LCFS and/or RFS. We expect this 'de-carbonization' process will benefit future production expansions at the Luverne Facility if implemented. 

As previously disclosed, during 2017, we hired a third-party engineering firm to test the structural integrity of two of our three carbon steel production fermentation vessels. The results of the testing indicate that one of these fermentation vessels had at least one more year of life before needing repair, and the other one had approximately two months of life remaining. In April 2019, we had an inspection done on a third carbon steel fermenter. Based on this inspection, we decided to retire this fermenter and use one of the recently repaired fermenters. Besides these three carbon steel production fermenters, we have two stainless steel production fermenters. 

Recently, we decided to repair two of the carbon steel fermentation vessels. Repairs are expected to be completed by the second quarter of 2019, at an estimated cost of approximately $0.6 million. After the repairs, the estimated useful life of the vessels is expected to be twenty-years.

 

Financial Condition

 

For the three monthsmonths ended March 31, 2019 and 2018,2020, we incurred a consolidated net loss of $6.1$9.3 million and, $2.5 million, respectively, andas of March 31, 2020, we had an accumulated deficit of $435.5 million at March 31, 2019.$467.2 million. Our cash and cash equivalents at March 31, 20192020 totaled $35.5$9.3 million, which is primarily being used for the following: (i) operating activities of our Luverne Facility; (ii) operating activities at our corporate headquarters in Colorado, including research and development work; (iii) capital expenditures primarily(ii) development costs associated with the Luverne Facility, including capital expenditures to “de-carbonize” the Luverne Facility; (iv)RNG; (iii) exploration of strategic alternatives and new financings; (iv) debt service obligations; and (v) debt service and repayment obligations.maintaining our Luverne Facility.

 

The continued operation of our business is dependent upon raising additional capital through future public and private equity offerings, debt financings or through other alternative financing arrangements. In addition, successful completion of our research and development programs and the attainment of profitable operations are dependent upon future events, including our ability to raise sufficient capital to expand our commercial production facility, completion of our development activities resulting in sales of isobutanol or isobutanol-derived products and/or technology, achieving market acceptance and demand for our products and services and attracting and retaining qualified personnel.

 

We expect to incur future net losses as we continue to fund the development and commercialization of our products and product candidates. We have primarily relied on raising capital to fund our operations and debt service obligations by issuing common stock and warrants in underwritten public offerings. Those issuances have caused significant dilution to our existing stockholders. While we have sought, and will continue to seek, other, less dilutive forms of financing to fund our operations and debt service obligations, there is no assurance that we will be successful in doing so.

 

Our transition to profitability is dependent upon, among other things, the successful development and commercialization of our products and product candidates, the achievement of a level of revenues adequate to support our cost structure and securing sufficient financing for the build-out and Retrofitexpansion of the Luverne Facility or a facility at another suitable location. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise additional cash. We intend to fund future operations through additional private and/or public offerings of debt or equity securities. In addition, we may seek additional capital through arrangements with strategic partners or from other sources, may seek to restructure our debt and we will continue to address our cost structure. Notwithstanding, there can be no assurance that we will be able to raise additional funds or achieve or sustain profitability or positive cash flows from operations.

 

25
32

 

Results of Operations

 

Comparison of the Three Months Ended March 31, 20192020 and 20182019

 

 Three Months Ended March 31,      Three Months Ended March 31,     

(in thousands)

 2019  

2018

  

Change

  2020  

2019

  

Change

 

Revenue and cost of goods sold

                        

Ethanol sales and related products, net

 $5,664  $8,218  $(2,554) $3,700  $5,664  $(1,964)

Hydrocarbon revenue

  739      739   125   739   (614)

Grant and other revenue

     25   (25)

Total revenues

  6,403   8,243   (1,840)  3,825   6,403   (2,578)
                     

Cost of goods sold

  8,961   10,583   (1,622)  8,139   8,961   (822)
                     

Gross loss

  (2,558)  (2,340

)

  (218)  (4,314)  (2,558

)

  (1,756)
                        

Operating expenses

                        

Research and development expense

  978   789   189   580   978   (398)

Selling, general and administrative expense

  2,092   1,870   222   2,783   2,092   691 

Restructuring costs

  299      299 
         

Total operating expenses

  3,070   2,659   411   3,662   3,070   592 
                        

Loss from operations

  (5,628)  (4,999

)

  (629)  (7,976)  (5,628

)

  (2,348)
                        

Other (expense) income

            

Other income (expense)

            

Interest expense

  (755)  (825

)

  70   (545)  (755

)

  210 

(Loss) on exchange of debt

     (21

)

  20 

(Loss) on modification of 2020 Notes

  (669)  

 

  (669)

Gain from change in fair value of derivative warrant liability

  1   477   (476)  7   1   6 

Gain from change in fair value of 2020 Notes embedded derivative

  246   2,858   (2,612)

(Loss) gain from change in fair value of 2020/21 Notes and 2020 Notes embedded derivative liability

  (100)  246   (346)

Other income

     8   (8)  30      30 

Total other expense, net

  (508)  2,497   (3,005)
         

Total other income (expense), net

  (1,277)  (508)  (769)
                        

Net loss

 $(6,136) $(2,502

)

 $(3,634) $(9,253) $(6,136

)

 $(3,117)

 

Revenue. Revenue from the sale of ethanol, isobutanol and related products for the three months ended March 31, 20192020 was $5.6$3.7 million, a decrease of $2.6$2.0 million fromcompared to the three months ended March 31, 2018.2019. This decrease was primarily the result of a combination of (i) decreased sales volumes of ethanol and distiller grains and (ii) a decline in ethanol prices for the three months ended March 31, 20192020 compared with the same period ended March 31, 2018.2019. During the three months ended March 31, 2019,2020, we sold 3.72.4 million gallons of ethanol compared to 4.93.7 million gallons of ethanol sold in the three months ended March 31, 2018. 2019.

 

Hydrocarbon revenues are comprised of ATJ, isooctane and isooctene sales. Hydrocarbon sales increaseddecreased by $0.7$0.6 million during the three months ended March 31, 20192020 as a result of greaterlower shipments of finished products from our demonstration plant located at the South Hampton Resources, Inc. facility near Houston, Texas (the “South Hampton Facility”).

 

Grant and other revenueCost of goods sold. Cost of goods sold was $0.0$8.1 million during the three months ended March 31, 2020, compared with $9.0 million during the three months ended March 31, 2019, a decrease of less than $0.1 million from the three months ended March 31, 2018.

Cost of goods sold. Cost of goods sold was $9.0 million during the three months ended March 31, 2019, compared with $10.6 million during the three months ended March 31, 2018, a decrease of approximately $1.6$0.8 million, primarily the result of decreased production for the three months ended March 31, 20192020 compared to March 31, 20182019 in response to an unfavorable commodity environment for the three months ended March 31, 2019.2020. Cost of goods sold included approximately $7.4$6.5 million associated with the production of ethanol and related products and approximately $1.6 million in depreciation expense during the three months ended March 31, 2019.2020.

 

Research and development expense. Research and development expense increaseddecreased by approximately $0.2$0.4 million during the three months ended March 31, 2019,2020, compared with the three months ended March 31, 2018,2019, due primarily to an increasea decrease in personnel and consulting expenses.

 

Selling, general and administrative expense. Selling, general and administrative expense increased by approximately $0.2$0.7 million during the three months ended March 31, 2019,2020, compared with the three months ended March 31, 2018,2019, due primarily to an increase in stock compensation expense.personnel and consulting expenses, partially offset by a decrease in professional fees.

 

33

Restructuring Costs. During the three months ended March 31, 2020, we incurred $0.3 million of restructuring charges related to the restructuring of Agri-Energy, termination of employees at Agri-Energy and Gevo and renegotiating contracts.

Interest expense. Interest expense during the three months ended March 31, 20192020 was $0.8$0.5 million, a decrease of $0.1$0.2 million compared to the three months ended March 31, 2018,2019, due to the exchangelower amortization of approximately $3.2 milliondebt discounts and debt issuance costs.

(Loss) from modification of our 12% convertible senior secured notes due 2020 (the “2020 Notes”) for our common stock during 2018, which resulted in a decrease in the outstanding principal amount of the 2020 Notes as of March 31, 2019.

26

Table of Contents

(Loss)/Gain from change in fair value of derivative warrant liability. Notes. During the three months ended March 31, 20192020, we incurred a $1,000 non-cash gain on changes in$0.7 million of legal and professional fees to modify the fair value of2020 Notes into the derivative warrant liability, primarily due to the decrease in the price of our common stock.2020/21 Notes.

 

(Loss) gain from change in fair value of the 2020/21 Notes and 2020 Notes embedded derivative.derivative liability. During the three months ended March 31, 2019,2020, the estimated fair value of the 20202020/21 Notes embedded derivative liability decreased,increased resulting in a non-cash gainloss of $0.2$0.1 million, primarily due to the decrease inrevaluation of the priceembedded derivative liability as a result of our common stock since the June 20, 2017 issuance date.modification of the 2020 Notes.

 

Revenue, CostSources of Goods Sold and Operating ExpensesOur Revenues

 

Revenue

During the three months ended March 31, 2019 and 2018, we generated revenueOur revenues are primarily derived from: (i) the sale of isobutanol, ethanol isobutanol and related products; (ii) hydrocarbon sales consisting primarily of the sale of ATJbiojet fuel isooctane and isoocteneisooctane derived from our isobutanol for purposes of certification and testing; and (iii) government grants and research and development programs. During the first quarter of 2020, we suspended for the foreseeable future our ethanol production at the Luverne Facility.

Principal Components of Our Cost Structure

 

Cost of Goods Sold and Gross LossSold. 

CostOur cost of goods sold during the three months ended March 31, 2019 and 2018consists primarily includesof costs directly associated with isobutanolethanol production and ethanolinitial operations for the production of isobutanol at the Luverne Facility such as costs for direct materials, direct labor, depreciation, other operating costs and certain plant overhead costs. Direct materials include corn feedstock, denaturant and process chemicals. Direct labor includes compensation of personnel directly involved in production operations at the Luverne Facility. Other operating costs include utilities and natural gas usage.

 

Our gross loss is defined as our total revenue less our cost of goods sold.

Research and DevelopmentDevelopment. 

Our research and development costs consist of expenses incurred to identify, develop and test our technologies for the production of isobutanol and the development of downstream applications thereof. Research and development expenses include personnel costs (including stock-based compensation), consultants and related contract research, facility costs, supplies, depreciation and amortization expense on property, plant and equipment used in product development, license fees paid to third parties for use of their intellectual property and patent rights and other overhead expenses incurred to support our research and development programs. Research and development expenses also include upfront fees and milestone payments made under licensing agreements and payments for sponsored research and university research gifts to support research at academic institutions.

Selling, General and AdministrativeAdministrative. 

Selling, general and administrative expenses consist of personnel costs (including stock-based compensation), consulting and service provider expenses (including patent counsel-related costs), legal fees, marketing costs, corporate insurance costs, occupancy-related costs, depreciation and amortization expenses on property, plant and equipment not used in our product development programs or recorded in cost of goods sold, travel and relocation expenses and hiring expenses.

 

We also record selling, generalInterest Expense. Our 2020/21 Notes have, and administrative expenses for the operations2020 Notes had, a fixed interest rate of 12%. As of March 31, 2020, the Luverne Facility that include administrative and oversight expenses, certain personnel-related expenses, insurance and other operating expenses.2020/21 Notes had a principal balance of $14.4 million. As of December 31, 2019, the 2020 Notes had a principal balance of $14.1 million.

 

Liquidity and Capital Resources

 

Since our inception in 2005, we have devoted most of our cash resources to manufacturing ethanol, isobutanol and related products, research and development and selling, general and administrative activities related to the commercialization of ethanol, isobutanol, as well as related products from renewable feedstocks. We have incurred losses since inception and expect to incur losses through at least 2020. We have financed our operations primarily with proceeds from multiple sales of equity and debt securities, borrowings under debt facilities and product sales.

 

27

Table of Contents

The continued operation of our business including any expansion of the Luverne Facility, is dependent upon raising additional capital through future public and private equity offerings, debt financings or through other alternative financing arrangements. In addition, successful completion of our research and development programs and the attainment of profitable operations are dependent upon future events, including accessour ability to raise sufficient capital repayment ofto expand our current debt,commercial production facility, completion of our development activities resulting in sales of isobutanol or isobutanol-derived products and/or technology, achieving market acceptance and demand for our products and services and attracting and retaining qualified personnel. Such

We expect to incur future net losses as we continue to fund the development and commercialization of our products and product candidates. We have primarily relied on raising capital to fund our operations and debt service obligations by issuing common stock and warrants in underwritten public offerings. Those issuances have caused significant dilution to our existing stockholders. While we have sought, and will continue to seek, other, less dilutive forms of financing to fund our operations and debt service obligations, there is no assurance that we will be successful in doing so.

34

Our transition to profitability is dependent upon, among other things, the successful development and commercialization of our products and product candidates, the achievement of a level of revenues adequate to support our cost structure and securing sufficient financing for the expansion of the Luverne Facility or a Retrofit facility at another suitable location. We may never achieve profitability or generate positive cash flows, and unless and until we do, we will continue to need to raise additional cash. We intend to fund future operations through additional private and/or public offerings of debt or equity securities. In addition, we may seek additional capital through arrangements with strategic partners or from other sources, may notseek to restructure our debt and we will continue to address our cost structure. Notwithstanding, there can be availableno assurance that we will be able to usraise additional funds or achieve or sustain profitability or positive cash flows from operations.

COVID-19

The rapidly evolving changes in financial markets could have a material impact on acceptable termsour ability to obtain financing, which could impact our liquidity. In addition the effectiveness of external parties, including governmental and non-governmental organizations, in combating the spread and severity of COVID-19 could have a material impact on demand for our business. Further, steps taken by market counterparties such as commercial airlines could have an impact on their ability to perform under agreements to which we are a party, which could impact our business. The rapid development and fluidity of this situation precludes any prediction as to the ultimate adverse impact of COVID-19 on our business.

COVID-19 could materially disrupt our own business operations and the services we provide, as well as the business operations of our customers, suppliers and other third parties with whom we interact. As an increasing percentage of our colleagues work remotely, we face the risk that unusual working arrangements could impact the effectiveness of our operations or at all.controls. A potential COVID-19 infection of any of our key colleagues could materially and adversely impact our operations. In addition, it is possible that COVID-19 restrictions could create difficulty for satisfying our legal or regulatory filing or other obligations, including with the SEC and other regulators.

 

As of March 31, 2019,2020, we had an accumulated deficit of $435.5$467.2 million with cash and cash equivalents totaling $35.5$9.3 million.

 

The following table sets forth the major sources and uses of cash for each of the periods set forth below (in thousands):

 Three Months Ended March 31, 
 Three Months Ended March 31,  2020  

2019

 
 2019  

2018

        

Net cash used in operating activities

 $(5,708) $(4,350

)

 $(6,988) $(5,708

)

Net cash used in investing activities

 $(2,204) $(67

)

 $(777) $(2,204

)

Net cash provided by/(used in) financing activities

 $9,644  $(107

)

Net cash provided by financing activities

 $752  $9,644

 

 

Operating Activities

 

Our primary uses of cash from operating activities are personnel-relatedpersonnel related expenses, research and development related expenses which includeincluding costs incurred under development agreements;agreements, costs andof licensing of technology, legal-related costs, expenses for the production of isobutanol, ethanol and related products, logistics costs, costs associated withand further processing of isobutanol and costs associated withethanol at the Luverne Facility and for the operation of theour South Hampton Facility and debt service payments.Facility.

 

During the three months ended March 31, 2019, we2020, net cash used for operating activities was $7.0 million compared to $5.7 million for the three months ended March 31, 2019. The $1.3 million decrease in operating cash from operating activities primarily resulting fromflows was due to reduced production at the Luverne Facility as a net lossresult of $6.1 million, a $1.6 million increase in working capital items, and approximately $2.0 million in non-cash operating activities.an unfavorable commodity environment, largely the result of greater corn costs as compared to national markets than the region has historically produced.

During the first quarter of 2020, we suspended for the foreseeable future our ethanol production at the Luverne Facility. We are currently maintaining the Luverne Facility until we arrange financing of its expansion for the production of hydrocarbons.

 

Investing Activities

 

During the three months ended March 31, 2019,2020, we used $2.2$0.8 million in cash fromfor investing activities, substantially all of which related primarily to capital expenditures at our Luverne Facility.Facility, of which $0.1 million related to the dry fractionation project and $0.6 million related to expanding our renewable hydrocarbon production capacity. We are installing equipment to fractionate and dry distillers grains at the Luverne Facility totaling approximately $3.0 million as of March 31, 2020. The cost of the fractionation machine and the thermal dryer have been funded with financing leases. No amounts are payable on these financing leases until the equipment is operational. The fractionation machine is expected to be operational in the first half of 2023.

We are developing a renewable electricity and RNG project comprised of anaerobic digesters to be located at three dairy farms in northwest Iowa, plus associated gas upgrading equipment, to commence the supply of RNG to the Luverne Facility in 2023 as a part of our RNG project initiative. We expect to finance the RNG project with approximately $57 million of combined project finance debt and third-party equity. Agri-Energy is expected to have a purchase option on approximately 50% of the RNG project’s estimated annual 350,000 MMBtu of RNG production. The digesters are expected to be operational in the second half of 2021, subject to securing adequate financing to complete the RNG project.

35

 

Financing Activities

 

During the three months ended March 31, 2019,2020, we raised approximately $9.6generated $0.8 million associated within cash from financing activities, which primarily consisted entirely of $9.6$0.9 million of net proceeds from sales under our “at-the-market”"at-the-market" offering program discussed below.below offset by $0.2 million paid on loans payable - other.

 

At-the-Market Offering Program. In February 2018, we commenced an at-the-market offering program, which allows us to sell and issue shares of our common stock from time-to-time. TheIn August 2019, the at-the-market offering program was amended multiple times during 2018 to increase theprovide available capacity under the at-the-market offering program by an aggregate of approximately $84.9$10.7 million.

During the three months ended March 31, 2019,2020, we issued 3,244,941425,776 shares of common stock under the at-the-market offering program for grossnet proceeds of $9.9 million. We paid$0.9 million net of commissions to our sales agent of approximately $0.2 million and incurred other offering related expenses of $0.01 million during the three months ended March 31, 2019.expenses. As of March 31, 2019,2020, we had remaining capacity to issue and sell up to approximately $34.7$7.8 million of additional shares of common stock under the at-the-market offering program. However, pursuant

Pursuant to Instruction I.B.6. to Form S-3, because the our market capitalization was below $75.0$75 million as of March 27, 2019, the date we filedof our Annual Report, on Form 10-K for the year ended December 31, 2018, we may only sell securities via Form S-3 if the aggregate market value of the securities sold by or on behalf of us during the 12-month period immediately prior to and including the date of the sale is no more than one-third of all common voting and nonvoting equity held by non-affiliates of us. Given the amount of common stock sold by us under the at-the-market offering program in 2018, we are currently unable to issue and sell additional shares of common stock under the at-the-market offering program.

 

20202020/21 Notes

 

On April 19, 2017, weJanuary 10, 2020, the Company entered into an Exchange and Purchase Agreement (the “Purchase(as amended, the “2020/21 Purchase Agreement”) with WB Gevo, LTD,the guarantors party thereto (the "Guarantors"), the holder of our 12.0% convertible senior secured notes due 2017 (such notes, the “2017 Notes” and, such holder, the “Holder”),2020 Notes and Whitebox Advisors LLC ("Whitebox"), in its capacity as representative of the Holder (“Whitebox”).holder. Pursuant to the terms of the 2020/21 Purchase Agreement, the Holder,holder of the 2020 Notes, subject to certain conditions, including approval of the transaction by our stockholders (which was received on June 15, 2017), agreed to exchange all of the outstanding principal amount of the 20172020 Notes, which was approximately $14.1 million including unpaid accrued interest, for an equalapproximately $14.4 million in aggregate principal amount of ourthe Company's newly created 20202020/21 Notes plus(the “2020/21 Exchange”). Pursuant to the 2020/21 Purchase Agreement, the Company also granted an option to purchase up to an additional aggregate principal amount in cashof approximately $7.1 million of 2020/21 Notes (the “2020/21 Option Notes”), at a purchase price equal to the accrued and unpaid interestaggregate principal amount of such 2020/21 Option Notes purchased less an original issue discount of 2.0%, having identical terms (other than interest paid in kind)with respect to the issue date and restrictions on transfer relating to compliance with applicable securities law) to the 2020/21 Notes issued, at any time during the period beginning on the 2017 Notes (the “Exchange”). On June 20, 2017, wedate of closing of the 2020/21 Exchange and ending on the later of (a) 180 days thereafter, and (b) 30 days following the date on which Stockholder Approval (as described below) is obtained. In addition, on January 10, 2020, the Company completed the 2020/21 Exchange terminated the 2017 Notes Indenture and cancelled the 20172020 Notes. AsIn addition, the Company entered into an Indenture by and among the Company, the guarantors named therein (the “2020/21 Notes Guarantors”) and FSB, as trustee and as collateral trustee (the “Original Indenture”), as supplemented by that certain First Supplemental Indenture, dated as of March 31, 2019April 7, 2020 (the “First Supplemental Indenture” and, December 31, 2018,together with the outstanding principalOriginal Indenture, the “2020/21 Notes Indenture”), pursuant to which the Company issued the 2020/21 Notes. The Company recognized an approximately $0.7 million loss on the 2020 Notes, including PIK Interest (as defined and described below), was $13.8 million and $13.8 million, respectively.2020/21 Exchange within the Consolidated Statements of Operations.

 

28
36

 

The 20202020/21 Notes will mature on MarchDecember 31, 2020, provided that the maturity date will automatically be extended to April 1, 2021 if (i) approval of a stockholder proposal is obtained prior to June 30, 2020 for the issuance of shares of our common stock under the 2020/21 Notes Indenture in excess of 19.99% of the outstanding shares of our common stock on the date of the Original Indenture (the “Stockholder Approval”), and (ii) the aggregate outstanding principal balance of the 2020/21 Notes (including any 2020/21 Option Notes) as of December 15, 2020.2020 is less than $7 million. The 20202020/21 Notes bear interest at a rate equal to 12% per annum (with 2%4% potentially payable as PIK Interest (as defined below) at our option), payable on March 31, June 30, September 30, and December 31 of each year. Under certain circumstances, we have the option to pay a portion of the interest due on the 20202020/21 Notes by either (a) increasing the principal amount of the 20202020/21 Notes by the amount of interest then due or (b) issuing additional 2020 Notes with a principal amount equal to the amount of interest then due (interest paid in the manner set forth in (a) or (b) being referred to as “PIK Interest”).

 

The 20202020/21 Notes are convertible into shares of our common stock, subject to certain terms and conditions. The initial conversion price of the 20202020/21 Notes is equal to $14.72$2.442 per share of common stock, or 0.06790.4095 shares of common stock per $1 principal amount of 2020 Notes.

 

See Note 7,9, Debt, to our consolidated financial statements included herein for further discussion of the 2020/21 Notes.

Loans Payable - Other

During the first quarter of 2020, Notes.we purchased equipment under a financing lease. During the fourth quarter of 2019, we financed part of our insurance obligation. The equipment notes and financing lease pay interest between 4% and 21%, have total monthly payments of $0.1 million and mature at various date from August 2020 to February 2025. The equipment loans are secured by the related equipment.

See Note 9, Debt, to our consolidated financial statements included herein for further discussion.

Small Business Administration Loans

In April 2020, the Company and Agri-Energy each entered into a loan agreement with Live Oak Banking Company, pursuant to which the Company and Agri-Energy obtained loans from the Small Business Administration's Paycheck Protection Program (“SBA PPP”) totaling $1.0 million in the aggregate (the "SBA Loans"). The SBA Loans will mature in April 2022 and bear interest at a rate equal to 1% per annum, subject to the potential for partial or full loan forgiveness as dictated by U.S. federal law. Principal and interest are deferred until November 2020 and interest continues to accrue during the deferral period. The SBA Loans are payable monthly beginning November 5, 2020, with aggregate payments totaling $0.06 million per month, including interest and principal. The SBA Loans must be used for payroll, rent payments, mortgage interest payments and utilities payments as governed by the SBA PPP and are subject to partial or full forgiveness for the initial eight-week period following the loan disbursement if all proceeds are used for eligible purposes and within certain thresholds, the Company maintains certain employment levels and the Company maintains certain compensation levels.

See Note 9, Debt, to our consolidated financial statements included herein for further discussion of the Small Business Administration Loans.

 

Critical Accounting Policies and Estimates

 

Except for the adoption of ASC 842 “Leases” (see Note 4) thereThere have been no significant changes to our critical accounting policies since December 31, 2018.2019. However, see Note 1, Nature of Business, Financial Condition and Basis of Presentation, to our consolidated financial statements included herein for a discussion of recently issued accounting pronouncements and their impact or future potential impact on our financial results, if determinable. For a description of critical accounting policies that affect our significant judgments and estimates used in the preparation of our consolidated financial statements, refer to our Annual Report.

 

Contractual Obligations and Commitments

The following summarizes the future commitments arising from our contractual obligations at March 31, 2019 (in thousands).

  

Less than 1 year

  

1 - 3 years

  

4 - 5 years

  

5+ Years

  

Total

 

Principal debt payments (1)

 $14,112  $-  $-  $-  $14,112 

Interest payments on debt (2)

  1,340   -   -   -   1,340 

Operating leases (3)

  1,238   654   -   -   1,892 

Insurance & Maintenance

  375   391   235   -   1,001 

Total

 $17,065  $1,045  $235   -  $18,345 

(1)

Represents cash principal payments due to the holders of the 2020 Notes.

(2)

Represents interest payments due to the holders of the 2020 Notes.

(3)

Represents commitments for operating leases related to our leased facility in Englewood, Colorado and our lease for rail cars in Luverne, Minnesota for ethanol and isobutanol shipments.

The table above reflects only payment obligations that are fixed and determinable as of March 31, 2019.

 

Off-Balance Sheet Arrangements

 

As of March 31, 2019,2020, we did not have any material off-balance sheet arrangements, except for operating lease obligations disclosed in our commitment and contingencies table above.obligations.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

Not Required.We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide information under this item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, that are designed to provide reasonable assurance that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and PrincipalChief Financial Officer, as appropriate, to allow timely decisions regarding required financial disclosures.

 

Management, including the participation of our Chief Executive Officer and our PrincipalChief Financial Officer, conducted an evaluation (pursuant to Rule 13a-15(b) of the Exchange Act) of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report.Report. Based on this evaluation, our Chief Executive Officer and PrincipalChief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2019.2020. In designing and evaluating our disclosure controls and procedures, management recognized that disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable but not absolute assurance that the objectives of the disclosure controls and procedures are met. The design of any disclosure control and procedure also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes in our internal control over financial reporting during the quarter ended March 31, 20192020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

From time to time, we have been and may again become involved in legal proceedings arising in the ordinary course of our business. We are not presently a party to any litigation that we believe to be material and we are not aware of any pending or threatened litigation against us that we believe could have a material adverse effect on our business, operating results, financial condition or cash flows.

 

Item 1A. Risk Factors.

 

You should carefully consider the risk factors discussed in Part I, Item 1A. “Risk Factors” in our Annual Report, which could materially affect our business, financial condition, cash flows or future results. ThereExcept as set forth below, there have been no material changes in our risk factors included in our Annual Report. The risk factors in our Annual Report are not the only risks facing our company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results.

 

Our business has been impacted by the COVID-19 pandemic, and our financial condition, results of operations and liquidity may be materially and adversely impacted by it in the future.

The COVID-19 pandemic has had an adverse impact on global commercial activity, including the global transportation industry and its supply chain, and has contributed to significant volatility in financial markets, including, among other effects, a decline in equity markets, changes in interest rates and reduced liquidity. It has also resulted in increased travel restrictions and extended shutdowns of businesses in various industries including, among others, the airline industry, and significantly reduced overall economic output. Although the COVID-19 pandemic did not have a material adverse impact to our financial results for the first quarter of 2020, we expect that the impact of the COVID-19 pandemic on general economic activity could negatively impact our revenue and operating results for the remainder of 2020. For example, in March 2020, following a temporary suspension of ethanol production at the Luverne Facility, we ultimately suspended production for the foreseeable future due to the impact of COVID-19 on the economy and our industry as a whole. There is also a risk that COVID-19 could have a material adverse impact on customer demand and cash flow.

The risks generally associated with the COVID-19 pandemic could magnify other risks discussed in this report and any of our SEC filings. For example, the rapidly evolving changes in financial markets could have a material impact on our ability to obtain financing, which could impact our liquidity. For example, volatility in the financial markets could make it more difficult to raise money from selling equity on the capital markets, the impact of COVID-19 on financial markets could limit potential lenders’ ability to provide funds for project finance of the planned expansion of the Luverne Facility or the terms of any project finance transactions could be worse than anticipated. In addition the effectiveness of external parties, including governmental and non-governmental organizations, in combating the spread and severity of COVID-19 could have a material impact on demand for our business. Further, steps taken by market counterparties such as commercial airlines could have an impact on their ability to perform under agreements to which we are a party, which could impact our business. For example, in connection with the impact that the COVID-19 pandemic has had on the economy and on the resulting disruption to the airline industry specifically, we and Delta amended portions of our previously disclosed Fuel Sales Agreement in April 2020, as discussed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Company Overview—COVID-19.” Other commercial counterparties may also seek to amend supply agreement in the future.

The COVID-19 pandemic could further and materially disrupt our own business operations and the services we provide, as well as the business operations of our customers, suppliers and other third parties with whom we interact. As an increasing percentage of our employees work remotely, we also face the risk that unusual working arrangements could impact the effectiveness of our operations or controls. In addition, a potential COVID-19 infection of any of our key employees could materially and adversely impact our operations. It is possible that COVID-19 restrictions could create difficulty for satisfying our legal or regulatory filing or other obligations, including with the SEC and other regulators.

All of the foregoing events or potential outcomes, including in combination with other risk factors included in this Quarterly Report on Form 10-Q or our Annual Report, could cause a material adverse effect on our results of operations in any period and, depending on their severity, could also materially and adversely affect our financial condition. In addition, such events and outcomes could potentially impact our reputation with clients and regulators, among others. The rapid development and fluidity of the pandemic precludes any prediction as to the ultimate impact of the COVID-19 pandemic on us. The full extent of the impact and effects of the COVID-19 pandemic on our business, operations, liquidity, financial condition and results of operations remain uncertain at this time.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

None.Issuer Purchases of Equity Securities

Period

 

Total Number

of Shares

Purchased

 

Average Price

Paid per Share

 

Total Number

of Shares

Purchased as

Part of Publicly

Announced

Plans or

Programs

 

Maximum

Number of

Shares that

May Yet Be

Purchased

Under the Plans

or Programs

January 1, 2020 - January 31, 2020

 

 

 

$

 

 

 

 

February 1, 2020 - February 29, 2020

 

 

 

$

 

 

 

 

March 1, 2020 - March 31, 2020 (1)

 

 

4,055

 

$

1.90

 

 

 

 

Total

 

 

4,055

 

$

1.90

 

 

 

 

(1)  Represents shares withheld from employees to cover tax withholding obligations upon the vesting of restricted stock awards. The average prices listed in the above table are averages of the fair market prices at which we valued shares withheld for purposes of calculating the number of shares to be withheld.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not Applicable.

 

Item 5. Other Information.

 

None.

 

Item 6. Exhibits.

 

The exhibits listed below are filed or furnished as part of this report. 

 

Exhibit

Number

 

 

Description

 

Previously Filed

 

Included

Herewith

 

 

 

 

 

Form

 

File No.

 

Filing Date

 

Exhibit

 

 

 

 

 3.1

 

 

Amended and Restated Certificate of Incorporation of Gevo, Inc.

 

 

10-K

 

 

001-35073

 

 

March 29, 2011

 

 

3.1

 

 

 

 

 3.2

 

 

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Gevo, Inc.

 

 

8-K

 

 

001-35073

 

 

June 10, 2013

 

 

3.1

 

 

 

 

 3.3

 

 

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Gevo, Inc.

 

 

8-K

 

 

001-35073

 

 

July 9, 2014

 

 

3.1

 

 

 

 

 3.4

 

 

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Gevo, Inc.

 

 

8-K

 

 

001-35073

 

 

April 22, 2015

 

 

3.1

 

 

 

 

 3.5

 

 

 

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Gevo, Inc.

 

 

8-K

 

 

001-35073

 

 

January 6, 2017

 

 

3.1

 

 

  3.6  

Certificate of Amendment to Amended and Restated Certificate of Incorporation of Gevo, Inc.

 8-K 001-35073 June 4, 2018 3.1  

 

 

 3.7

 

 

Amended and Restated Bylaws of Gevo, Inc.

 

 

10-K

 

 

001-35073

 

 

March 29, 2011

 

 

3.2

 

 

 

 

 4.1

 

 

Form of the Gevo, Inc. Common Stock Certificate.

 

 

S-1

 

 

333-168792

 

 

January 19, 2011

 

 

4.1

 

 

 

 

 4.2

 

 

 

Fifth Amended and Restated Investors’ Rights Agreement, dated March 26, 2010.

 

 

S-1

 

 

333-168792

 

 

August 12, 2010

 

 

4.2

 

 

 

 

 4.3†

 

 

 

Stock Issuance and Stockholder’s Rights Agreement, dated July 12, 2005, by and between Gevo, Inc. and California Institute of Technology.

 

 

S-1

 

 

333-168792

 

 

August 12, 2010

 

 

4.3

 

 

 

 

Exhibit

Number

 

 

Description

 

Previously Filed

 

Included

Herewith

 

 

 

 

 

Form

 

File No.

 

Filing Date

 

Exhibit

 

 

 

 

 4.4

 

 

 

Exchange and Purchase Agreement, dated April 19, 2017, by and among Gevo, Inc., the guarantors party thereto, the holders named in Schedule I thereto, and Whitebox Advisors LLC, in its capacity as representative of the holders.

 

 

8-K

 

 

001-35073

 

 

April 20, 2017

 

 

4.1

 

 

 

 

 4.5

 

 

 

Indenture, dated June 20, 2017, by and among Gevo, Inc., the guarantors party thereto, and Wilmington Savings Fund Society, FSB, as trustee and collateral trustee.

 

 

8-K

 

 

001-35073

 

 

June 20, 2017

 

 

4.1

 

 

 

 

 4.6

 

 

 

Registration Rights Agreement, dated June 20, 2017, by and among Gevo, Inc. and the investors named therein.

 

 

8-K

 

 

001-35073

 

 

June 20, 2017

 

 

4.2

 

 

 

 

 4.7

 

 

 

Common Stock Unit Warrant Agreement, dated August 5, 2014, by and between Gevo, Inc. and the American Stock Transfer & Trust Company, LLC.

 

 

8-K

 

 

001-35073

 

 

August 6, 2014

 

 

4.1

 

 

 

 

 4.8

 

 

 

2015 Common Stock Unit Series A Warrant Agreement, dated February 3, 2015, by and between Gevo, Inc. and the American Stock Transfer & Trust Company, LLC.

 

 

8-K

 

 

001-35073

 

 

February 4, 2015

 

 

4.1

 

 

 

 

 4.9

 

 

 

2015 Common Stock Unit Series C Warrant Agreement, dated May 19, 2015 by and between Gevo, Inc. and the American Stock Transfer & Trust Company LLC.

 

 

8-K

 

 

001-35073

 

 

May 20, 2015

 

 

4.1

 

 

 

 

 4.10

 

 

Form of Series D Warrant to Purchase Common Stock.

 

 

8-K

 

 

001-35073

 

 

December 15, 2015

 

 

4.1

 

 

 

 

 4.11

 

 

Form of Amendment No. 1 to Series D Warrant

 

 

8-K

 

 

001-35073

 

 

June 13, 2016

 

 

4.1

 

 

Exhibit

Number

 

 

Description

 

Previously Filed

 

Included

Herewith

 

 

 

 

 

Form

 

File No.

 

Filing Date

 

Exhibit

 

 

 

 

 4.4*

 

 

 

Indenture, dated January 10, 2020, by and among Gevo, Inc., the guarantors party thereto, and Wilmington Savings Fund Society, FSB, as trustee and as collateral trustee.

 

 

8-K

 

 

001-35073

 

 

January 13, 2020

 

 

4.1

 

 

 

 4.5 

  First Supplemental Indenture, by and among Gevo, Inc., the guarantors party thereto, Wilmington Savings Fund Society, FSB, as trustee and as collateral trustee, the requisite holders and Whitebox Advisors LLC. 8-K 001-35073 April 9, 2020 4.1  

 

 

 4.6

 

 

 

Registration Rights Agreement, dated January 10, 2020, by and among Gevo, Inc. and the investors named therein.

 

 

8-K

 

 

001-35073

 

 

January 13, 2020

 

4.1

 

 

 

 

 

 4.7

 

 

 

2015 Common Stock Unit Series C Warrant Agreement, dated May 19, 2015 by and between Gevo, Inc. and the American Stock Transfer & Trust Company LLC.

 

 

8-K

 

 

001-35073

 

 

May 20, 2015

 

 

4.1

 

 

 

 

 4.8

 

 

Form of Series D Warrant to Purchase Common Stock.

 

 

8-K

 

 

001-35073

 

 

December 15, 2015

 

 

4.1

 

 

 

 

 4.9

 

 

Form of Amendment No. 1 to Series D Warrant

 

 

8-K

 

 

001-35073

 

 

June 13, 2016

 

 

4.1

 

 

 

 

Exhibit

Number

 

 

Description

 

Previously Filed

 

Filed

Herewith

 

 

 

 

 

Form

 

File No.

 

Filing Date

 

Exhibit

 

 

 

 

 4.12

 

 

Form of Series F Warrant to Purchase Common Stock.

 

 

8-K

 

 

001-35073

 

 

April 5, 2016

 

 

4.1

 

 

 

 

 413

 

 

Form of Series I Warrant to Purchase Common Stock

 

 

8-K

 

 

001-35073

 

 

September 15, 2016

 

 

4.1

 

 

 

 

 4.14

 

 

Form of Series K Warrant to Purchase Common Stock

 

 

8-K

 

 

001-35073

 

 

February 22, 2017

 

 

4.1

 

 

 

 

 31.1

 

 

Section 302 Certification of the Principal Executive Officer.

 

 

 

 

 

 

 

 

 

 

X

 

 

 31.2

 

 

Section 302 Certification of the Principal Financial Officer.

 

 

 

 

 

 

 

 

 

 

X

 

 

 32.1

 

 

Section 906 Certification of the Principal Executive Officer and Principal Financial Officer.**

 

 

 

 

 

 

 

 

 

 

X**

 

 

 101

 

 

 

Financial statements from the Quarterly Report on Form 10-Q of Gevo, Inc. for the quarterly period ended March 31, 2019, formatted in XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Cash Flows, and (iv) Notes to the Consolidated Financial Statements.

 

 

 

 

 

 

 

 

 

 

X

Exhibit

Number

 

 

Description

 

Previously Filed

 

Filed

Herewith

 

 

 

 

 

Form

 

File No.

 

Filing Date

 

Exhibit

 

 

 

 

 4.10

 

 

Form of Series F Warrant to Purchase Common Stock.

 

 

8-K

 

 

001-35073

 

 

April 5, 2016

 

 

4.1

 

 

 

 

 4.11

 

 

Form of Series I Warrant to Purchase Common Stock

 

 

8-K

 

 

001-35073

 

 

September 15, 2016

 

 

4.1

 

 

 

 

 4.12

 

 

Form of Series K Warrant to Purchase Common Stock

 

 

8-K

 

 

001-35073

 

 

February 22, 2017

 

 

4.1

 

 

  10.1 #  Offer Letter, dated February 22, 2018, by and between Gevo, Inc. and Timothy J. Cesarek.         X
  10.2 *  Exchange and Purchase Agreement, dated January 10, 2020, by and among Gevo, Inc., the guarantors party thereto, the holders named in Schedule I thereto, and Whitebox Advisors LLC, in its capacity as representative of the holders. 8-K 001-35073 January 13, 2020 10.1  
  10.3  Letter Agreement, dated April 7, 2020, by and among Gevo, Inc., the guarantors party thereto and Whitebox Advisors LLC, for itself and on behalf of the holders. 8-K 001-35073 April 9, 2020 10.1  
  10.4††  Amendment No. 1 to Fuel Sales Agreement, dated as of April 22, 2020, by and between the Company and Delta Air Lines, Inc. 8-K 001-35073 April 28, 2020 10.1  

 

 

 31.1

 

 

Section 302 Certification of the Principal Executive Officer.

 

 

 

 

 

 

 

 

 

 

X

 

 

 31.2

 

 

Section 302 Certification of the Principal Financial Officer.

 

 

 

 

 

 

 

 

 

 

X

 

 

 32.1

 

 

Section 906 Certification of the Principal Executive Officer and Principal Financial Officer.**

 

 

 

 

 

 

 

 

 

 

X**

 

 

 101

 

 

 

Financial statements from the Quarterly Report on Form 10-Q of Gevo, Inc. for the quarterly period ended March 31, 2020, formatted in XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Operations, (iii) the Consolidated Statements of Cash Flows, and (iv) Notes to the Consolidated Financial Statements.

 

 

 

 

 

 

 

 

 

 

X

 

Certain portions have been omitted pursuant to a confidential treatment request. Omitted information has been filed separately with the SEC.

††Certain portions of the exhibit have been omitted pursuant to Rule 601(b)(10) of Regulation S-K. The omitted information is (i) not material and (ii) would likely cause competitive harm to the Company if publicly disclosed. of the exhibit 
*Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K under the Securities Exchange Act of 1934, as amended.

 

**

Furnished herewithherewith.

#Indicates a management contract or compensatory plan or arrangement.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

Gevo, Inc.

(REGISTRANT)

 

 

By:

/s/ Bradford K. TowneCarolyn M. Romero

 

Bradford K. TowneCarolyn M. Romero, CPA

VP - Controller

ChiefPrincipal Accounting Officer

(Principal Financial and Accounting Officer)

 

Date: May 8, 201912, 2020

 

44

35